CA2200489A1 - Expandable, intraluminal stents - Google Patents
Expandable, intraluminal stentsInfo
- Publication number
- CA2200489A1 CA2200489A1 CA002200489A CA2200489A CA2200489A1 CA 2200489 A1 CA2200489 A1 CA 2200489A1 CA 002200489 A CA002200489 A CA 002200489A CA 2200489 A CA2200489 A CA 2200489A CA 2200489 A1 CA2200489 A1 CA 2200489A1
- Authority
- CA
- Canada
- Prior art keywords
- stent
- accordance
- rigid
- spokes
- end supports
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
- A61F2002/9511—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
Abstract
An expandable, intraluminal stent (10) is provided which can be inserted into a body passage, and is capable of supporting an intact vascular graft (25).
The stent is a thin-walled, generally tubular member having a plurality of rigid support tabs (15) spaced uniformly around the perimeter of the two ends of the stent. A plurality of spacer bars (17) span longitudinally between the rigid support tabs at one end of the stent and corresponding rigid support tabs at the other end. The spacer bars serve as struts to prevent longitudinal expansion or contraction of the stent so that the length of the stent is maintained. Plastically deformable connecting links (16) interconnect adjacent rigid support tabs around each end of the stent to enable the stent to be expanded to an enlarged diameter. The stent can be expanded with a delivery system (43-49) which applies a radially, outwardly extending force from the exterior of the stent. Aternatively, the stent can be expanded using an angioplasty balloon.
The stent is a thin-walled, generally tubular member having a plurality of rigid support tabs (15) spaced uniformly around the perimeter of the two ends of the stent. A plurality of spacer bars (17) span longitudinally between the rigid support tabs at one end of the stent and corresponding rigid support tabs at the other end. The spacer bars serve as struts to prevent longitudinal expansion or contraction of the stent so that the length of the stent is maintained. Plastically deformable connecting links (16) interconnect adjacent rigid support tabs around each end of the stent to enable the stent to be expanded to an enlarged diameter. The stent can be expanded with a delivery system (43-49) which applies a radially, outwardly extending force from the exterior of the stent. Aternatively, the stent can be expanded using an angioplasty balloon.
Description
220~4 ~1 WO 96tOgO13 PCT/US95/10931 ~an~ . Tntr~ l"minal 8tent9 Field of the Invent;on The present invention relates to an e~r~n~hle, intraluminal stent and an apparatus and a method for deploying the eYp~nA~hle, intraluminal stent in a body passage. More particularly, the present invention relates to a type of intraluminal stent capable of ~p~o ~ing an intact, intraluminal, venous graft providing an inner stent lining having an endothelial layer and an apparatus and method for deploying and mech~nically eYp~n~ing the vein-lined stent within a body r~sr-ge through the application of an outward force on the ~xternal surface of the stent.
Background of the Invent;on As an alternative to vascular surgery, balloon angioplasty has been a common method for unblorki~g narrowed or occluded blood vessels. In this procedure, an angioplasty balloon is inflated within a steno~A vessel in order to dilate the vessel to provide an enlarged lumen. Altho~lg~ balloon angioplasty has been s~lccessful in restoring flow in stenotic or occluded vessels, these vessels often restenose due to elastic recoil of the diseased tissue. Subintimal Ais~ction is also caused by balloon induced stresses and results in geometric irregularities at the inner wall leading to flow disturh~nces and decreased flow.
220 0~
WO96/09013 PCT~S95/10931 Con~equently, intraluminal stenting has been used with increasing frequency to improve the sl~cc~ss rate of transluminal balloon angioplasty. These tllhlll A~ stents are il.~,G~ ce~ via catheter, ~YpAn~
to a preset diameter and left in situ to resist elastic recoil and to hold A issections against the vessel wall. There are essentially three types of conventional stents all of which are metallic. The three types are balloon eYpAn~hle, self-expandable, and memory metals (i.e., nitinol). The balloon-eY~An~hle stents deform plastically beyond the elastic limit of the material and are relatively rigid at their ~YpAnAed diameter. The balloon expAn~hle stents are mounted over a deflated angioplasty balloon and then positioned within a vessel. The balloon is then inflated transmitting outward radial forces across the t~h~lAr stent that plastically deforms into a final larger diameter against the vessel wall. The balloon is then deflated and removed from the vessel.
Self-exrAn~hle stents rely on the potential energy stored in a reduced diameter to spring back to some new, larger diameter when released. Self-expandable stents tend to be more compliant than balloon-~YpAn~Ahle stents- Self-eYrAn~Ahle stents are compressed into a smaller diameter and then inserted into a sheath. The sheath is then inserted into a vessel and removed at the desired location to expose the stent. The compressed stent springs open against the vessel wall exerting a constant outward force thereby fixing the stent in place. Memory metal or nitinol stents assume a final enlarged diameter from an initial r~ ce~ diameter in the presence of temperature changes. Nitinol stents, along with resorbable polymeric stents, are not as widely used as balloon- and self-eYpAn~Ahle stents. Memory metal Wo96tO9013 2 2 0 3 ~ ~ S PCT~S95/10931 stents respond to temperature changes by changing from a r~uGeA diameter to a final ~YpAn~ed configuration at the stenotic site.
;
Although patency rates have improved when stenting is used in conjunction with balloon angioplasty, thrombosis and neointimal hyperplasia within the region of the stent continue to compromise the potential utility of these devices. Stent surface thrombogenicity and processes regulating neointimal lo hyperplasia are considered to be major contributors to the long-term problems associated with conventional stenting.
Ultimately, endothelialization of the stent surface properly represents the best chance for sllcceccful use of a stent since the endothelial layer has the potential to inhibit low-flow thrombosis and to moderate factors involved in maintaining luminal patency. The course of events leading to endothelialization of any metallic stent surface begins with thrombus formation at the stent surface.
The thrombogenicity of the stent surface is dependent on surface characteristics such as the electronegative potential of the metal and surface roughness.
Thrombus that initially forms is eventually replaced by fibromu~c~lAr tissue, fibrocytes and collagen.
Endothelialization is allowed to proceed across the newly formed tissue from the endothelial cells eYrose~
between the stent latticework and from the ends of the stent. The extent to which endothelialization occurs ~eren~-c upon the number of cells to survive the trauma of stent deployment as well as the flow conditions set up by the introduction of the stent. Minimization of mech~nically induced trauma to the endothelial lining 22û04 .
Wo96/oso13 PCT~S95/10931 of the vessel certainly becomes desirable.
Accordingly, a stent design achieving a low ratio of metal ~urface area to open surface area therefore becomes desirable to reduce thrombogenicity while maximizing the potential for endothelialization.
Another factor to be considered is that blood flow is altered by the presence of a stent.
Troughs created along the stented segment of the vessel create turbulence, boundary layer separation, and regions of potentially low flow and low shear.
These kinds of flow conditions have been implicated as a mechAni-cm for atherogenesis. Accordingly, a stent having an open structural design appears to be desirable.
lS Next, most conventional stents undergo longitllAinAl shortening with an increase in diameter.
In the presence of arterial smooth muscle contraction/relaxation and pulsatile flow, length changes likely accompany diameter changes.
Endothelium may be slc~ghe~ as a result and an additional inflammatory reaction may ensue due to relative motion at the ctent-tissue interface. The foreshorteni~g of conventional stents within the target location also creates problems in deployment accuracy and potentiates further damage to the wall of the vein at the target location. Accordingly, reducing or eliminating longitll~inAl shortening of the stent during eyrAncion also becomes a desirable goal.
It is well known that the endothelial layer, formed by the cells lining the inner wall of a vessel, is a dynamic layer that is able to produce, secrete, 221~04~9 WO96/09013 PCT~S9~/10931 and modulate factors involved in maintaining patency of the vessel lumen. These endothelial properties are tho~yht to be the reason venous ron~llits have significantly higher patency rates than synthetic grafts when used in arterial reconstructions.
Combining the properties of endothelium and stents would therefore be desirable to create a better endoprosthesis. Specifically, a stent lined with an endothelial layer would be less thrombogenic.
Additionally, the vessel wall, which is likely to be injured by the angioplasty, would be largely shielded from blood-borne comrQnents such as platelets which are known to be potent instigators of neointimal hyperplasia. Lastly, the stent itself would still retain its ability to counteract the elastic recoil of the vessel wall following angioplasty.
Accordingly, it would be highly desirable to have a stent that reAllceC surface contact with the vessel wall, that inhibits longitll~inAl shortening during eYrAncion and that ~ ~o~s a venous lining to provide an inner endothelial layer.
Summarv of the Invention In accordance with the present invention, an eYpA~hle~ intraluminal stent is provided for 2S deployment in a body passage, such as a blood vessel, to inhibit vessel stenosis. The stent in accordance with the present invention is easy to deploy, is made of metal so that it can be imaged during deployment, demonstrates a high eYrAncion ratio, counteracts - 30 elastic recoil of the vAFclllAr wall, and has a non-thrombogenic surface. Furthermore, because of its unique configuration, the stent does not shorten 22504~9 WOg6/09013 PCT~S95/10931 following eYrAneion. The stent also enables vein grafts or other biocompatible materials or surfaces to be mounted within its lumen without compromise of endothelial integrity or creation of vein graft reAl~n~nGy.
A stent delivery ~ystem and method are also provided in accordance with the present invention for illL~Gd~cing and deploying the stent within a selected body passage such as a constricted, diseased or lo injured vAFclll~r site. Generally, the stent is deployed by a me~nism that exerts an outward force on the external surface of the stent to ~Y~AnA the stent to an enlarged diameter, thereby leaving its luminal environment undi&Lu~bed.
lS The stent is a generally thin-walled, mesh-like, t~lhlll~r structure having a central lumen. The stent includes a plurality of rigid support tabs, in the form of end ~ ~G~ LS, which are positioned in an annular arrangement to form a ring at each end of the stent. The rigid support tabs are uniformly spaced around the periphery of each end of the stent. As a result, the rigid end ~~ 1'~~ LS are disposed in the respective ring so that each end support is positioned diametrically oppo~~A to another one of the end supports in the ring. The rigid ~u~ L tabs at one end of the stent are A i SrOFeA generally opposite corresronAing rigid ~ -o~L tabs at the other end of the stent. A plurality of spacer bars, in the form of rigid struts, are used to co~nect the rigid support tabs at the one end of the stent to the opposite rigid .l-olL tabs at the other end of the stent. The spacer bars span longit~l~in~lly between the support tabs and serve as struts to maintain the length of the 223 G4 ~ .
wos6lo9ol3 PCT~S95/10931 stent. A plurality of plastically deformable connecting links are used to interconnect adjacent support tabs along the circumference of each end of the stent, so that the stent is eYpAnA~hle to an enlarged diameter through plastic deformation of the rQnn?cting links which thereby serve to maintain the stent in its eYr~nA~A configuration.
A further feature of the present invention is that an endothelial layer provided by a vein lo segment can be attached to the stent prior to deployment of the stent. The vein segment can be positioned within the central lumen of the stent and then attached to the stent using sutures.
The stent delivery apparatus comprises a lS drive unit and a catheter having a stent deployment mech~n;sm. The stent deployment mechanism is disposed at the distal end of the stent delivery apparatus and is designed to ~Yr~nA the stent by applying a radially, outwardly extenAinq force from the exterior of the stent. The stent deployment mechAnism is operably connected to the drive unit so that operation of the drive unit controls operation of the stent deployment mechAnism.
The stent deployment mechAnicm comprises a uniform bundle of ~po~e~ attached to the distal end of a ~GJ.L~ ol cable that interconnocts the deployment me~h~nism with the drive unit. Free ends of the ~pokec are pA~seA through corresponding coupling tubes att~h~A to the exterior of the stent for releasably coupling the spokes to the stent. The free ends of the CpQk~c are then loosely held in place by a conical tip which is attached to the distal end of a central 2200~P
WO96/09013 PCT~S95/10931 guidewire from the a~,.LLol cable. The guidewire is co~Yi~l with an outer flexible tube and is freely movable within the flexible tube. The guidewire extends from the flexible tube and passes through the lumen of the stent along a central axis of the bundle of nroke~. Movement of the guidewire into the flexible tube causes the ~rokec to flex outwardly thereby exerting an outward external force on the stent causing the stent to dilate. Subse~uent movement of the guidewire out of the tube causes the free ends of the spokes to spring free of the conical tip. Withdrawal of the stent deployment mec~nism away from the ~Yr~nA~A stent then causes the freed spokes to disengage from the coupling tubes of the stent.
Brief Descri~tion of the Drawinqs The foregoing summary~ as well as the following detailed description of the preferred embodiments of the present invention, will be better underctood when read in conjunction with the accompanying drawings, in which:
Fig. 1 is an enlarged perspective view of an eYrAn~hle intraluminal stent in accordance with the present invention and a delivery apparatus also in accordance with the present invention for inserting the stent into the lumen of a body passage and for ~Yr~ g the stent;
Fig. 2 is an enlarged, schematic end elevational view of the stent in its uneYr~n~ed configuration;
2200'i~
WO96/09013 PCT~S95/10931 Fig. 3 is an enlarged, schematic side elevational view of the stent in its llne~pAn~ed configuration;
Fig. 4a is an enlarged side elevational view of the stent and a tool having a vein segment thereon, depicting a method for attaching the vein segment to the stent, using tissue adhesive, just prior to insertion of the vein segment within the lumen of the stent;
Fig. 4b is an enlarged side elevational view of the stent and a tool having a vein segment thereon, depicting a method for inserting the vein segment into the lumen of the stent and for attaching the vein segment to the stent using tissue adhesive, just prior to inflation of the vein segment within the stent;
Fig. 4c is an enlarged side elevational view of the stent with the vein segment inserted within the lumen of the stent, depicting a method for attaching a vein segment to the stent using tissue adhesive, following curing of the tissue adhesive;
Fig. 5 is an enlarged cross sectional view of the stent showing a vein segment attached to the stent with ~L~es;
Fig. 6 is an enlarged side elevational view of the stent deployment mech~nism~ with several wire spokeR removed, located at the distal end of the delivery apparatus used to deploy the stent in the body passage;
220û4S9 W096/09013 PCT~S95/10931 Fig. 7 is an enlarged end elevational view of the stent deployment mechA~i-em located at the distal end of the delivery apparatus used to deploy the stent in the body pAe~-ge;
Fig. 8 is an enlarged plan view of the drive unit located at the proximal end of the delivery apparatus used to deploy the stent in the body passage;
Fig. 9a is an enlarged, schematic cross sectional view of the stent deployment mechanism at the distal end of the delivery apparatus with a pair of the wire spokes shown in an unflexed position;
Fig. 9b is an enlarged, schematic cross sectional view of the distal end of the delivery apparatus with a pair of the wire spokes shown in a flexed position;
Fig. lOa is an enlarged side elevational view of the stent mounted on the stent deployment mech~nism of the delivery apparatus in an un~Yp~n~ed configuration;
Fig. lOb is an enlarged side elevational view of the stent mounted on the stent deployment mec~nism of the delivery apparatus with the wire spokec in position for eYpAneion of the stent;
Fig. lOc is an enlarged side elevational view of the stent mounted on the stent deployment mechAnism of the delivery apparatus following p~neion of the stent;
221J~i4~',' Wog6/osol3 PCT~S95/10931 Fig. lOd is an enlarged side elevational - view of the stent and the stent deployment meçhAnism of the delivery apparatus in position for removal of the stent deployment mec~nism from the ~YpAn~P~ stent while leaving the ~YrAn~ stent within the lumen of the body passage;
Fig. 11 is an enlarged, cross-sectional view of a hll~hing for the stent deployment merhAnism for guiding movement of the wire spokes in accordance with another emho~iment of the present invention;
Fig. 12 is an enlarged, exploded perspective view of the frustaconical tip of the stent deployment meçhAni~m for receiving the free ends of the wire Cpok~c for use with the h-lching shown in Fig. 11;
Fig. 13 is an enlarged, cross-sectional view of the frustaconical tip shown in Fig. 12;
Fig. 14 is an enlarged perspective view of a stent in accordance with another preferred emho~iment of the present invention;
Fig. 15 is an enlarged side elevational view of a stent deployment meçh~nism having the wire spokes removed, located at the distal end of the delivery apparatus in accordance with another emho~iment of the present invention;
Fig. 16 is an enlarged, exploded perspective view of a hl~hi~g for the stent deployment mechAnism shown in Fig. 15;
22304~, WO96/09013 PCT~S95/10931 Fig. 17 i8 an enlarged, exploded perspective view of the frustaconical tip of the stent deployment me~nism shown in Fig. 15;
Fig. 18 is an enlarged side elevational view of a swing arm for the stent deployment mechAnicm shown in Fig. 15;
Fig. l9a is an enlarged, schematic perspective view of a h~lC~ing in an unflexed position for a stent deployment mechanism in accordance with yet another emho~iment of the present invention; and Fig. l9b is an enlarged, schematic perspective view of the b~ching shown in Fig. l9a but in the flexed position.
Detailed Description of the Preferred Embodiments Referring to Fig. 1, a stent delivery apparatus, generally designated 8, is depicted for deploying a generally ~llh~ r, thin-walled stent 10 within a selected body passage such as a stenosed vessel. The stent delivery apparatus 8 serves as a catheter for inserting the stent 10 into the selected body passage. For this purpose, the tubular stent 10 is removably mounted on a stent deployment mechanism, generally designated 40, in the form of a wire bundle disposed at a distal end of the stent delivery apparatus 8.
Control of the stent deployment mech~nism 40 is effected by a manually-operable drive unit 48 in the form of a rack and pinion microdrive. The drive
Background of the Invent;on As an alternative to vascular surgery, balloon angioplasty has been a common method for unblorki~g narrowed or occluded blood vessels. In this procedure, an angioplasty balloon is inflated within a steno~A vessel in order to dilate the vessel to provide an enlarged lumen. Altho~lg~ balloon angioplasty has been s~lccessful in restoring flow in stenotic or occluded vessels, these vessels often restenose due to elastic recoil of the diseased tissue. Subintimal Ais~ction is also caused by balloon induced stresses and results in geometric irregularities at the inner wall leading to flow disturh~nces and decreased flow.
220 0~
WO96/09013 PCT~S95/10931 Con~equently, intraluminal stenting has been used with increasing frequency to improve the sl~cc~ss rate of transluminal balloon angioplasty. These tllhlll A~ stents are il.~,G~ ce~ via catheter, ~YpAn~
to a preset diameter and left in situ to resist elastic recoil and to hold A issections against the vessel wall. There are essentially three types of conventional stents all of which are metallic. The three types are balloon eYpAn~hle, self-expandable, and memory metals (i.e., nitinol). The balloon-eY~An~hle stents deform plastically beyond the elastic limit of the material and are relatively rigid at their ~YpAnAed diameter. The balloon expAn~hle stents are mounted over a deflated angioplasty balloon and then positioned within a vessel. The balloon is then inflated transmitting outward radial forces across the t~h~lAr stent that plastically deforms into a final larger diameter against the vessel wall. The balloon is then deflated and removed from the vessel.
Self-exrAn~hle stents rely on the potential energy stored in a reduced diameter to spring back to some new, larger diameter when released. Self-expandable stents tend to be more compliant than balloon-~YpAn~Ahle stents- Self-eYrAn~Ahle stents are compressed into a smaller diameter and then inserted into a sheath. The sheath is then inserted into a vessel and removed at the desired location to expose the stent. The compressed stent springs open against the vessel wall exerting a constant outward force thereby fixing the stent in place. Memory metal or nitinol stents assume a final enlarged diameter from an initial r~ ce~ diameter in the presence of temperature changes. Nitinol stents, along with resorbable polymeric stents, are not as widely used as balloon- and self-eYpAn~Ahle stents. Memory metal Wo96tO9013 2 2 0 3 ~ ~ S PCT~S95/10931 stents respond to temperature changes by changing from a r~uGeA diameter to a final ~YpAn~ed configuration at the stenotic site.
;
Although patency rates have improved when stenting is used in conjunction with balloon angioplasty, thrombosis and neointimal hyperplasia within the region of the stent continue to compromise the potential utility of these devices. Stent surface thrombogenicity and processes regulating neointimal lo hyperplasia are considered to be major contributors to the long-term problems associated with conventional stenting.
Ultimately, endothelialization of the stent surface properly represents the best chance for sllcceccful use of a stent since the endothelial layer has the potential to inhibit low-flow thrombosis and to moderate factors involved in maintaining luminal patency. The course of events leading to endothelialization of any metallic stent surface begins with thrombus formation at the stent surface.
The thrombogenicity of the stent surface is dependent on surface characteristics such as the electronegative potential of the metal and surface roughness.
Thrombus that initially forms is eventually replaced by fibromu~c~lAr tissue, fibrocytes and collagen.
Endothelialization is allowed to proceed across the newly formed tissue from the endothelial cells eYrose~
between the stent latticework and from the ends of the stent. The extent to which endothelialization occurs ~eren~-c upon the number of cells to survive the trauma of stent deployment as well as the flow conditions set up by the introduction of the stent. Minimization of mech~nically induced trauma to the endothelial lining 22û04 .
Wo96/oso13 PCT~S95/10931 of the vessel certainly becomes desirable.
Accordingly, a stent design achieving a low ratio of metal ~urface area to open surface area therefore becomes desirable to reduce thrombogenicity while maximizing the potential for endothelialization.
Another factor to be considered is that blood flow is altered by the presence of a stent.
Troughs created along the stented segment of the vessel create turbulence, boundary layer separation, and regions of potentially low flow and low shear.
These kinds of flow conditions have been implicated as a mechAni-cm for atherogenesis. Accordingly, a stent having an open structural design appears to be desirable.
lS Next, most conventional stents undergo longitllAinAl shortening with an increase in diameter.
In the presence of arterial smooth muscle contraction/relaxation and pulsatile flow, length changes likely accompany diameter changes.
Endothelium may be slc~ghe~ as a result and an additional inflammatory reaction may ensue due to relative motion at the ctent-tissue interface. The foreshorteni~g of conventional stents within the target location also creates problems in deployment accuracy and potentiates further damage to the wall of the vein at the target location. Accordingly, reducing or eliminating longitll~inAl shortening of the stent during eyrAncion also becomes a desirable goal.
It is well known that the endothelial layer, formed by the cells lining the inner wall of a vessel, is a dynamic layer that is able to produce, secrete, 221~04~9 WO96/09013 PCT~S9~/10931 and modulate factors involved in maintaining patency of the vessel lumen. These endothelial properties are tho~yht to be the reason venous ron~llits have significantly higher patency rates than synthetic grafts when used in arterial reconstructions.
Combining the properties of endothelium and stents would therefore be desirable to create a better endoprosthesis. Specifically, a stent lined with an endothelial layer would be less thrombogenic.
Additionally, the vessel wall, which is likely to be injured by the angioplasty, would be largely shielded from blood-borne comrQnents such as platelets which are known to be potent instigators of neointimal hyperplasia. Lastly, the stent itself would still retain its ability to counteract the elastic recoil of the vessel wall following angioplasty.
Accordingly, it would be highly desirable to have a stent that reAllceC surface contact with the vessel wall, that inhibits longitll~inAl shortening during eYrAncion and that ~ ~o~s a venous lining to provide an inner endothelial layer.
Summarv of the Invention In accordance with the present invention, an eYpA~hle~ intraluminal stent is provided for 2S deployment in a body passage, such as a blood vessel, to inhibit vessel stenosis. The stent in accordance with the present invention is easy to deploy, is made of metal so that it can be imaged during deployment, demonstrates a high eYrAncion ratio, counteracts - 30 elastic recoil of the vAFclllAr wall, and has a non-thrombogenic surface. Furthermore, because of its unique configuration, the stent does not shorten 22504~9 WOg6/09013 PCT~S95/10931 following eYrAneion. The stent also enables vein grafts or other biocompatible materials or surfaces to be mounted within its lumen without compromise of endothelial integrity or creation of vein graft reAl~n~nGy.
A stent delivery ~ystem and method are also provided in accordance with the present invention for illL~Gd~cing and deploying the stent within a selected body passage such as a constricted, diseased or lo injured vAFclll~r site. Generally, the stent is deployed by a me~nism that exerts an outward force on the external surface of the stent to ~Y~AnA the stent to an enlarged diameter, thereby leaving its luminal environment undi&Lu~bed.
lS The stent is a generally thin-walled, mesh-like, t~lhlll~r structure having a central lumen. The stent includes a plurality of rigid support tabs, in the form of end ~ ~G~ LS, which are positioned in an annular arrangement to form a ring at each end of the stent. The rigid support tabs are uniformly spaced around the periphery of each end of the stent. As a result, the rigid end ~~ 1'~~ LS are disposed in the respective ring so that each end support is positioned diametrically oppo~~A to another one of the end supports in the ring. The rigid ~u~ L tabs at one end of the stent are A i SrOFeA generally opposite corresronAing rigid ~ -o~L tabs at the other end of the stent. A plurality of spacer bars, in the form of rigid struts, are used to co~nect the rigid support tabs at the one end of the stent to the opposite rigid .l-olL tabs at the other end of the stent. The spacer bars span longit~l~in~lly between the support tabs and serve as struts to maintain the length of the 223 G4 ~ .
wos6lo9ol3 PCT~S95/10931 stent. A plurality of plastically deformable connecting links are used to interconnect adjacent support tabs along the circumference of each end of the stent, so that the stent is eYpAnA~hle to an enlarged diameter through plastic deformation of the rQnn?cting links which thereby serve to maintain the stent in its eYr~nA~A configuration.
A further feature of the present invention is that an endothelial layer provided by a vein lo segment can be attached to the stent prior to deployment of the stent. The vein segment can be positioned within the central lumen of the stent and then attached to the stent using sutures.
The stent delivery apparatus comprises a lS drive unit and a catheter having a stent deployment mech~n;sm. The stent deployment mechanism is disposed at the distal end of the stent delivery apparatus and is designed to ~Yr~nA the stent by applying a radially, outwardly extenAinq force from the exterior of the stent. The stent deployment mechAnism is operably connected to the drive unit so that operation of the drive unit controls operation of the stent deployment mechAnism.
The stent deployment mechAnicm comprises a uniform bundle of ~po~e~ attached to the distal end of a ~GJ.L~ ol cable that interconnocts the deployment me~h~nism with the drive unit. Free ends of the ~pokec are pA~seA through corresponding coupling tubes att~h~A to the exterior of the stent for releasably coupling the spokes to the stent. The free ends of the CpQk~c are then loosely held in place by a conical tip which is attached to the distal end of a central 2200~P
WO96/09013 PCT~S95/10931 guidewire from the a~,.LLol cable. The guidewire is co~Yi~l with an outer flexible tube and is freely movable within the flexible tube. The guidewire extends from the flexible tube and passes through the lumen of the stent along a central axis of the bundle of nroke~. Movement of the guidewire into the flexible tube causes the ~rokec to flex outwardly thereby exerting an outward external force on the stent causing the stent to dilate. Subse~uent movement of the guidewire out of the tube causes the free ends of the spokes to spring free of the conical tip. Withdrawal of the stent deployment mec~nism away from the ~Yr~nA~A stent then causes the freed spokes to disengage from the coupling tubes of the stent.
Brief Descri~tion of the Drawinqs The foregoing summary~ as well as the following detailed description of the preferred embodiments of the present invention, will be better underctood when read in conjunction with the accompanying drawings, in which:
Fig. 1 is an enlarged perspective view of an eYrAn~hle intraluminal stent in accordance with the present invention and a delivery apparatus also in accordance with the present invention for inserting the stent into the lumen of a body passage and for ~Yr~ g the stent;
Fig. 2 is an enlarged, schematic end elevational view of the stent in its uneYr~n~ed configuration;
2200'i~
WO96/09013 PCT~S95/10931 Fig. 3 is an enlarged, schematic side elevational view of the stent in its llne~pAn~ed configuration;
Fig. 4a is an enlarged side elevational view of the stent and a tool having a vein segment thereon, depicting a method for attaching the vein segment to the stent, using tissue adhesive, just prior to insertion of the vein segment within the lumen of the stent;
Fig. 4b is an enlarged side elevational view of the stent and a tool having a vein segment thereon, depicting a method for inserting the vein segment into the lumen of the stent and for attaching the vein segment to the stent using tissue adhesive, just prior to inflation of the vein segment within the stent;
Fig. 4c is an enlarged side elevational view of the stent with the vein segment inserted within the lumen of the stent, depicting a method for attaching a vein segment to the stent using tissue adhesive, following curing of the tissue adhesive;
Fig. 5 is an enlarged cross sectional view of the stent showing a vein segment attached to the stent with ~L~es;
Fig. 6 is an enlarged side elevational view of the stent deployment mech~nism~ with several wire spokeR removed, located at the distal end of the delivery apparatus used to deploy the stent in the body passage;
220û4S9 W096/09013 PCT~S95/10931 Fig. 7 is an enlarged end elevational view of the stent deployment mechA~i-em located at the distal end of the delivery apparatus used to deploy the stent in the body pAe~-ge;
Fig. 8 is an enlarged plan view of the drive unit located at the proximal end of the delivery apparatus used to deploy the stent in the body passage;
Fig. 9a is an enlarged, schematic cross sectional view of the stent deployment mechanism at the distal end of the delivery apparatus with a pair of the wire spokes shown in an unflexed position;
Fig. 9b is an enlarged, schematic cross sectional view of the distal end of the delivery apparatus with a pair of the wire spokes shown in a flexed position;
Fig. lOa is an enlarged side elevational view of the stent mounted on the stent deployment mech~nism of the delivery apparatus in an un~Yp~n~ed configuration;
Fig. lOb is an enlarged side elevational view of the stent mounted on the stent deployment mec~nism of the delivery apparatus with the wire spokec in position for eYpAneion of the stent;
Fig. lOc is an enlarged side elevational view of the stent mounted on the stent deployment mechAnism of the delivery apparatus following p~neion of the stent;
221J~i4~',' Wog6/osol3 PCT~S95/10931 Fig. lOd is an enlarged side elevational - view of the stent and the stent deployment meçhAnism of the delivery apparatus in position for removal of the stent deployment mec~nism from the ~YpAn~P~ stent while leaving the ~YrAn~ stent within the lumen of the body passage;
Fig. 11 is an enlarged, cross-sectional view of a hll~hing for the stent deployment merhAnism for guiding movement of the wire spokes in accordance with another emho~iment of the present invention;
Fig. 12 is an enlarged, exploded perspective view of the frustaconical tip of the stent deployment meçhAni~m for receiving the free ends of the wire Cpok~c for use with the h-lching shown in Fig. 11;
Fig. 13 is an enlarged, cross-sectional view of the frustaconical tip shown in Fig. 12;
Fig. 14 is an enlarged perspective view of a stent in accordance with another preferred emho~iment of the present invention;
Fig. 15 is an enlarged side elevational view of a stent deployment meçh~nism having the wire spokes removed, located at the distal end of the delivery apparatus in accordance with another emho~iment of the present invention;
Fig. 16 is an enlarged, exploded perspective view of a hl~hi~g for the stent deployment mechAnism shown in Fig. 15;
22304~, WO96/09013 PCT~S95/10931 Fig. 17 i8 an enlarged, exploded perspective view of the frustaconical tip of the stent deployment me~nism shown in Fig. 15;
Fig. 18 is an enlarged side elevational view of a swing arm for the stent deployment mechAnicm shown in Fig. 15;
Fig. l9a is an enlarged, schematic perspective view of a h~lC~ing in an unflexed position for a stent deployment mechanism in accordance with yet another emho~iment of the present invention; and Fig. l9b is an enlarged, schematic perspective view of the b~ching shown in Fig. l9a but in the flexed position.
Detailed Description of the Preferred Embodiments Referring to Fig. 1, a stent delivery apparatus, generally designated 8, is depicted for deploying a generally ~llh~ r, thin-walled stent 10 within a selected body passage such as a stenosed vessel. The stent delivery apparatus 8 serves as a catheter for inserting the stent 10 into the selected body passage. For this purpose, the tubular stent 10 is removably mounted on a stent deployment mechanism, generally designated 40, in the form of a wire bundle disposed at a distal end of the stent delivery apparatus 8.
Control of the stent deployment mech~nism 40 is effected by a manually-operable drive unit 48 in the form of a rack and pinion microdrive. The drive
2 2 0 0 Q ~~ 9 PCT~S95tl~31 unit 48 is ~i~ro~~~ at a proximate end of the stent delivery apparatus 8 and is attached to the stent deployment mech~n;sm 40 by a flexible control cable 49. Manual operation of the drive unit 48 controls operation of the stent deployment mechanism 40 so that the stent 10 can be safely deployed at a selected target location within a body passage whereupon the stent deployment mech-n;sm 40 and the control cable 41 are then withdrawn from the body leaving the stent 10 properly deployed at the target location.
Referring to Figs. 2 and 3, the stent 10 is in the form of a generally tubular mesh-like configuration providing a central lumen along its longit~;n~l axis. The generally tubular stent 10 includes a series of tab-like rigid supports 15 which are disposed in a generally similar arrangement at each end of the tubular stent 10. The rigid support tabs 15 of the stent are generally equally spaced apart around the circular perimeter at each end of the stent 10. In addition, the rigid support tabs 15 are disposed so that a rigid s~rport tab 15 at one end of the stent is substantially opposite a corresponding rigid support tab 15 at the other end of the stent 10.
Spacer bars 17 ~O~ QCt each rigid su~o~L tab 15 at one end of stent 10 to an opposite corresponding rigid support tab 15 at the other end of the stent. The spacer bars 17 serve as struts to prevent the stent from foreshortPn;ng along its longitll~inAl axis. Each spacer bar 17 thereby serves to maintain corresponding pairs of ~ ~~L tabs 15 at opposite ends of the stent in position relative to the longitl~; nA 1 axis of the tubular stent. The spacer bars are also sufficiently rigid to resist bowing or hpn~ing in the transverse direction relative to the stent. As shown 2 2 0 ~; .
W096/09013 PCT~S9StlO931 schematically in Fig. 2, the ~ o~L tabs 15 at each end of the stent are positioned adjacent to one another in a generally ~nnll 1 Ar arrangement around the periphery of each end of the stent so that each r~ lG~ tab 15 has a diametrically opposing support tab 15 at each end of the stent. A series of deformable connecting links 16 in the form of plastically-deformable, U-shaped, wire-like links are used to connect adjacent rigid support tabs 15 around the annular arrangement of the support tabs at each end of stent 10, so that the stent 10 can be diametrically eY~nA~A through plastic deformation of the connecting links 16. As the stent is diametrically eYp~nAed, the connecting links 16 bend so that the stent maintains its generally tubular shape. The central lumen of the stent widens but the spacer bars 17 inhibit longitll~inAl movement of the ~ o~ tabs thereby maintaining the overall length of the stent. The stent 10 may be expanded by applying a radially, outwardly ext~nAing force from the exterior of the ctent. For this purpose, external expansion couplings, in the form of coupling tubes 18, are oriented longit~lAin~lly relative to the stent and are attached on the spacer bars 17 along the outside of the stent 10. For example, the coupling tubes 18 can be fabricated from 0.5" (12.7 mm) lengths of 26 gauge hypodermic tubing and attached with laser welds 19 to the exterior of the spacer bars 17 and the support tabs 15, making sure that the lumen of each coupling tube 18 remains open and intact. Alternatively, the stent 10 may be fabricated by extruding the stent 10 as one piece. Deployment of stent 10 may then be - effected using the delivery apparatus 8. The coupling tubes 18 permit the stent 10 to be removably mounted on the stent deployment mechanism 40 of the stent 220()4~
Referring to Figs. 2 and 3, the stent 10 is in the form of a generally tubular mesh-like configuration providing a central lumen along its longit~;n~l axis. The generally tubular stent 10 includes a series of tab-like rigid supports 15 which are disposed in a generally similar arrangement at each end of the tubular stent 10. The rigid support tabs 15 of the stent are generally equally spaced apart around the circular perimeter at each end of the stent 10. In addition, the rigid support tabs 15 are disposed so that a rigid s~rport tab 15 at one end of the stent is substantially opposite a corresponding rigid support tab 15 at the other end of the stent 10.
Spacer bars 17 ~O~ QCt each rigid su~o~L tab 15 at one end of stent 10 to an opposite corresponding rigid support tab 15 at the other end of the stent. The spacer bars 17 serve as struts to prevent the stent from foreshortPn;ng along its longitll~inAl axis. Each spacer bar 17 thereby serves to maintain corresponding pairs of ~ ~~L tabs 15 at opposite ends of the stent in position relative to the longitl~; nA 1 axis of the tubular stent. The spacer bars are also sufficiently rigid to resist bowing or hpn~ing in the transverse direction relative to the stent. As shown 2 2 0 ~; .
W096/09013 PCT~S9StlO931 schematically in Fig. 2, the ~ o~L tabs 15 at each end of the stent are positioned adjacent to one another in a generally ~nnll 1 Ar arrangement around the periphery of each end of the stent so that each r~ lG~ tab 15 has a diametrically opposing support tab 15 at each end of the stent. A series of deformable connecting links 16 in the form of plastically-deformable, U-shaped, wire-like links are used to connect adjacent rigid support tabs 15 around the annular arrangement of the support tabs at each end of stent 10, so that the stent 10 can be diametrically eY~nA~A through plastic deformation of the connecting links 16. As the stent is diametrically eYp~nAed, the connecting links 16 bend so that the stent maintains its generally tubular shape. The central lumen of the stent widens but the spacer bars 17 inhibit longitll~inAl movement of the ~ o~ tabs thereby maintaining the overall length of the stent. The stent 10 may be expanded by applying a radially, outwardly ext~nAing force from the exterior of the ctent. For this purpose, external expansion couplings, in the form of coupling tubes 18, are oriented longit~lAin~lly relative to the stent and are attached on the spacer bars 17 along the outside of the stent 10. For example, the coupling tubes 18 can be fabricated from 0.5" (12.7 mm) lengths of 26 gauge hypodermic tubing and attached with laser welds 19 to the exterior of the spacer bars 17 and the support tabs 15, making sure that the lumen of each coupling tube 18 remains open and intact. Alternatively, the stent 10 may be fabricated by extruding the stent 10 as one piece. Deployment of stent 10 may then be - effected using the delivery apparatus 8. The coupling tubes 18 permit the stent 10 to be removably mounted on the stent deployment mechanism 40 of the stent 220()4~
3 PCT~S95/10931 delivery apparatus 8. The coupling tubes 18 also serve the ~ ? of reinforcing the spacer bars 17 to inhibit compression and/or eYrAncion of the stent along its longit~i n~ 1 axis thereby functioning as a strut and to inhibit henA i ~g or collapsing of the stent in the transverse direction. In an alternative arrangement, the coupling tubes 18 may be used instead of the spacer bars 17 with the ends of the coupling tubes being attached, by laser welding, to the corresponding support tabs 15 at opposite ends of the stent thereby serving the function of the spacer bars 17. In yet another alternative arrangement, the stent may be used without the coupling tubes 18 in which case the stent can be eYr~n~ from the inside at the target location using a balloon-type catheter delivery system. Since the stent is plastically deformed, there is very little recoil and the stent resists being recompressed.
In a particular emho~iment~ the stent 10 is fabricated from a single piece of continuous tube with no welds or solder points. For example, a 316L grade seamless stainless steel tube with an outer diameter of 0.125" (3.175 mm), a nominal wall thickness of 0.006" (0.1524 mm), and an overall length of 0.5"
(12.7 mm) may be used. Six rectangular regions of material are removed from each end of the tube so that material remains for six rigid support tabs 15. The ~u~G~ L tabs are thin, generally arcuate, and conform in shape to the stent in the first direction.
Deformable ronn~cting links 16 and spacer bars 17 are formed by removing six generally H-sh~pe~ regions 11 from the central portion of the tube thereby forming open areas in the tubular stent. Thus, the stent 10 has a general tubular structure having a thin-walled 22 JO$~S
WO96/09013 PCT~S95/10931 lattice frame with sren;ngs in the frame. Wire electrical A i~~h~rge mac~ini ng or wire EDM can be used for removing sections of the tubing to extremely high precision without creating burrs or deformations. The wire diameter for cutting can be approximately 0.010"
(0.254 mm) resulting in corners that are radiused to 0.005" (0.127 mm). Using this method a stent 10 can be made with rigid D~G~L tabs 15 that are 0.0625"
(1.588 mm) long by 0.0625" (1.588 mm) wide, spacer bars 17 that are 0.374" (9.5 mm) long by 0.020"
(0.508 mm) wide and connecting links 16 that are 0.004" (0.102 mm) wide relative to the circumference of the stent. After full ~yp~ncion~ the stent 10 can assume a final diameter of approximately 0.315"
(8.0 mm) or 2.5 times its original diameter.
The total intimal surface area along a stented segment of a vessel can be approximated from the equation for the surface area of a tube, or ~dl, where d is the stent diameter and l is the stent length. For a stented region corresponding to the stent 10 of the type shown schematically in Fig. 3 with the above dimensions, the estimated total intimal surface area is ~(8.0)(12.7)= 319.20 mm2. The total surface area of the stent, with coupling tubes made from 26 gauge hypodermic tubing, that can be exposed to the vessel lumen is estimated to be 99.02 mm2.
Using geometrical constraints, the area of metallic surface in contact with intimal tissue is estimated to be 54.43 mm2. Expressed in terms of percent open area within the stented segment, the stent of the present invention is therefore estimated to be 82.95~ open.
This result suggests that the stent of the present invention is capable of preserving a large area of endothelialized tissue. In addition, the amount of WO96/09013 2 2 IJ O ~ '~ ', PCT~S95/10931 metallic surface ~YrQ~~~ to the blood is kept relatively low.
Construction of the stent lO is not limited to ~tainle~s steel. The ~tent lO can be made from any material which is compatible with the human body and any bodily fluids that the stent lO may contact.
However, the stent lO must be made from a material that allows for ~YrAncion of stent lO and must be able to maintain its eYrAnA~ shape while disposed within the lumen of the body passage. In addition to stainless steel, suitable materials for construction of stent lO may include tantalum and titanium. The stent lO can also be fabricated from a memory metal such as nitinol. In addition, the stent lO does not have to be fabricated from a single piece of continuous tube. For example, the spacer bars 17 and/or the connecting links 16 can be made separately from the rigid ~y~O~ tabs 15 and attached using, for example, laser welding techniques. Alternatively, the stent lO may be fabricated by extruding the stent lO
as one piece.
While the stent may be deployed as a "stand alone" device, the stent may also be effectively used as a vA~c~llAr endograft by attaching a segment of vein, preferably an autologous vein or a synthetic graft material within the central lumen of the stent.
Preferably, an autologous vein segment is utilized to provide an endothelial layer as a lining for the lumen of the stent. As shown in Figs. 4a - 4c, a vein segment 25 may be attached to the inner surface of the stent lO by, for example, using tissue adhesive 29.
As shown in Fig. 4a, the vein segment 25 is attached to a piece of tubing 26 with suture 27, which is in 221l0~J~
WO96/09013 PCT~S95110931 turn attached to a syringe filled with isotonic saline. The free end of the vein segment 25 is then closed with ~ Le 28. The vein segment 25 is deflated using the syringe and, as shown in Fig. 4b, the vein segment is then inserted into the lumen of the stent 10. A small amount of tissue adhesive 29 is applied to multiple points along the inner surface of the stent 10. As shown in Fig. 4c, the vein segment 25 is then inflated 80 that the outer surface of the vein segment 25 contacts the inner surface of stent 10 especially at the points where tissue adhesive 29 has been applied. Once the ti~sue adhesive 29 has cured, the vein segment 25 is disconnected from the tubing 26 and the eYc~ss vein segment 25 is trimmed at each end of the stent.
The use of tissue adhesive to secure the vein segment to the stent may not always be suitable or permitted. Accordingly, a vein segment may be attached to the stent 10 in accordance with a preferred method of using sutures 30. As shown in Fig. 5, a length of vein segment 25 about twice as long as the length of stent 10 is used. The vein segment 25 is inserted within the lumen of stent 10 so that the stent is generally centered about the vein segment 25. The ends of the vein segment 25 are then everted over the ends of stent 10 so as to completely line the inner surface of stent 10 and to substantially cover the outer surface of stent 10.
After slightly crimping the stent 10 onto the external surface of the vein segment 25, the proximal and distal ends of the vein segment 25 are secured to the adventitia with interrupted 7.0 proline sutures between each spacer bar 17. Accordingly, a stent-vein 2 2 3 ~J 4 ~, WO96/0~13 PCT~S95/10931 complex is provided for deployment at the target location by the stent delivery apparatus lO.
The stent delivery apparatus 8 includes a ~tent deployment mech~n~sm 40, as shown in Figs. 6 and 7, manually operated by drive unit 48, as shown in Fig. 8. The drive unit 48 (Edmund Scientific, Barrington, NJ, model ~J3650) is connected with the stent deployment mechAnifim 40 by control cable 49.
The stent deployment mechanism 40 includes a series of six spokes 42 each connected at one end to a bushing 43. The spokes 42 may be in the form of a symmetric bundle of six spring steel wires of diameter .008 inches (.203 mm) bonded to the outer wall of the htlC~ing 43 which is in the form of a 316L grade stainless steel tube having a length of approximately .25 inches (6.35 mm), an outer diameter of .0732 inches (l.86 mm) and an inner diameter of .05 inches (l.28 mm). The free ends of the spokec removably nest within conical tip 45 di~ at the end of a central guidewire 44 in the form of stainless steel wire having a diameter of .04 inc-h~s (l mm). When the guidewire 44 is moved to retract the tip 45 toward the cable 49, the free ends of the spokes can be positioned to nest within the tip 45. When the guidewire 44 is moved to displace the tip 45 away from the cable 49 the free ends of the spokes 42 are released as shown in Fig. 6.
In cable 49, the central guidewire 44 is coaxially contained within a flexible guide tube 41 in the form of a polymer tubing, such as flexible nylon tubing having the same inner and outer diameters as the h~l~hing 43. The hn~h;ng 43 is bonded to one end of the guide tube 41 using, for example, epoxy, spot WO96/09013 220a$~9 PCT~S95/10931 welding, or soldering t~chniques. The junction between the h -C~ ing 43 and the guide tube 41 is enclosed within an external junction sleeve 39 in the form of a ~tainles~ steel tube segment. The other end of the flexible guide tube extends with the guidewire 44 approximately 30 inr~eC to the drive unit 48 shown in Fig. 8. The drive unit functions to displace the guidewire 44 through the flexible guide tube 41 in a controlled manner by manual rotation of actuator knob 38. The guidewire 44 and the flexible guide tube 41 are enclosed within an outer sheath tube 46 in the form of a polymer tube such as a clear polyethylene or teflon tubing that is approximately 30 inches long.
As best shown in Figs. 1 and 6, the end of the sheath tube 46 at the stent deployment mechanism is capped by a sheath cap 47 in the form of 316L grade stainless steel tubing having a length of approximately 2 inches. The sheath cap 47 serves as a rigid housing for accommodating the wire spoke bundle 42 when the sheath cap is slid over the wire spoke bundle. The sheath tube 46 may be manually retracted relative to flexible tube 41 and guidewire 44 to displace the sheath cap 47 from the wire spoke bundle 42 in order to expose the wire spoke bundle. Flexible tube 41, guidewire 44, and outer sheath 46 are concentric and allowed to move relative to each other along their axes.
The proximal ends of flexible tube 41 and guidewire 44 are attached to the linear microdrive unit 48, which allows for the axial movement of guidewire 44 relative to flexible tube 41. As knob 38 is turned an internal rack and pinion drive mechanism longitllAin~lly displaces the central guidewire 44 relative to the flexible inner tube 41. As 22uo4a~
WO 96/OgO13 PCr/USgS/10931 schematically depicted in Fig. 9a, when the tip 45 of the guidewire 44 is positioned in its mid-position the free ends of the spokes 42 are captured within the tip 45 but the spokes remain relatively extended, or S unflexed, between the tip 45 and the hllching 43. As schematically depicted in Fig. 9b, when the guidewire 44 is deployed so the tip 45 moves toward the h ~rhing 43 at the distal end of flexible tube 41, croke~ 42 are caused to bend and flex outwardly.
In an alternative emhoAiment of the stent deployment mech~ c-m~ the spokes 42 are attached to flexible tube 41' by hlt-ch;ng 43', as depicted in Fig.
11, which serves as a hl-ching for the guidewire 44'.
The spokes 42 may be made from spring steel wires of diameter 0.008" (0.203 mm). The h~ ing 43' is a brass cylindrical section with à frustaconical end having an outer diameter of 0.138" (3.5 mm), an inner diameter of 0.042" (1.079 mm), and a length of 0.335"
(8.5 mm). An inner bore 56 is provided through the hl~hing to permit the flexible tube 41' and the guidewire 44' to pass therethrough. The cross section of the inner bore 56 of h~lching 43' is not circular but instead includes flattened sidewall sections to prevent the hllching 43' from rotating around the flexible tube 41'. The flexible tube 41' is made from ABS plastic tubing with an approximate 3" (76.2 mm) length of the distal end of the flexible tube 41' being ~peA with flattened sidewall sections to mate with inner bore 56. Six ~mall angled bores 50 are drilled at 30~ relative to the longitudinal axis of the hllching at the distal end of the bllching 43'. The bores 50 are approximately 0.010" (0.254 mm) in diameter and widen to approximately 0.020" (0.005 mm) at the periphery of the hll~ching. The bores are WO96/09013 PCT~S95/10931 substantially equally spaced around the distal end of the kl~hi~g 43~ to accommodate the spokes 42, which are epoxy glued in place within the bores 50. The b~l~hing 43' is epoxy bQn~Q~ about the distal end of the flexible tube 41'. The flexible tube 41' extends from the hllChi~ for 30" before being connected to the linear microdrive unit 48. In addition, the outer sheath 46 is constructed from teflon tubing approximately 30" (76.2 cm) in length with an inner diameter sufficiently large to form a slip fit over the bllching 43'. Attached to the distal end of the outer sheath 46 is a tubular end cap 47 which is fabricated from a 316L grade stainless steel tubing approximately 2" (50.8 mm) in length and with similar inner and outer diameters to the outer sheath 46. The end cap 47 serves as a rigid housing that accommodates spokes 42 when the spokes 42 are withdrawn sufficiently into the end cap 47.
As depicted in Figs. 12 and 13, a frustaconical tip 45' of the catheter is used in conjunction with the hl)ching 43' depicted in Fig 11.
The tip 45' is fabricated from two brass sections, 60 and 61, having outer diameters of approximately 0.138"
(3.5 mm) and inner diameters of approximately 0.042"
(1.079 mm). The first section is generally cylindrical with a frustaconical end. The second section is generally cylindrical. A central aligned bore 55 extends through the Fecon~ section and into the first section. The cross cection of the inner bores 55 of the two tubular sections 60 and 61 are not circular but instead have flattened sidewall sections, as shown in Fig. 12, to prevent the tip 45' from rotating around the guidewire 44'. The guidewire 44' is made from narrow hypodermic tubing with an 22 ~-t 8 , Wos6/o9ol3 PCT~S95/10931 approximately 3" (76.2 mm) length of the distal end of the guidewire 44' being shaped with flattened exterior sidewall sections to mate with inner bore 55. The first section 60 of the tip 45' has a length of approximately 0.236" (6 mm) and the second section 61 of the tip 45' has a length of 0.010" (2.5 mm). Six small radially oriented bore holes 51, approximately 0.020" (0.508 mm) in diameter, are drilled at 30~
angles relative to the longitl~;n~l axis of the central bore 55. The bore holes 51 are uniformly spaced around the proximal end of the first section 60 to accommodate the free ends of the spokes 42, which are loosely held in place. Small exterior longitllAinal slots 52, 0.020" (0.508 mm) deep and 0.020" (0.508 mm) wide, are milled along the second section 61 to act as guide slots for the spokes 42.
The longitllA i nA 1 slots 52 confine the movement of the spokes 42 to a radial direction in a plane through the longitllAinAl axis of the ceconA section 61 and inhibit lateral movement of the spokec 42 out of the plane.
The proximal end of the first section 60 is held by friction fit on the end of the guidewire 44' in abutment with the distal end of the second section 61, so that the slots 52 along the second section 61 register with the bore holes 51 drilled in the first section 60. Alternatively, the first section 60 and the second section 61 can be attached using epoxy or spot welding techniques.
Yet another emhoAiment of the stent deployment mechanism 40 is depicted in Figs. 15-18.
The hllching 143 is fabricated from two abutting brass sections, 173 and 174. The first section 173 has a larger cylindrical portion at the distal end that tapers into a frustaconical section which terminates 220u~
WO96/09013 PCT~S95/10931 in a smaller cylindrical section at the proximate end of the first section. The F~con~ ~ection 174 is generally cylindrical. The two abutting sections 173 and 174 have outer diameters of 0.138" (3.5 mm), inner diameters of 0.042" (1.079 mm), and a combined overall length of 0.335~ (8.5 mm). An inner bore 156 passes through both sections. The cross section of the inner bore 156 of the two t~h~ r sections 173 and 174 is sized and ~p~A to mate with the distal end of the flexible tube 41 and to prevent the bushing 143 from rotating around the flexible tube 41. The second section 174 has a circular groove 182 milled into the proximal end of the second tubular section 174. The circular groove 182 is concentric with the inner bore 156. In addition, small external longitudinal slots 180 are milled along the second tubular section 174. A series of six swing arms 176, having spoke su~olL tubes 177 attAchD~ to ball bearings 178, serve as hinges and are disposed with the ball bearings 178 positioned within the circular groove 182, which serves as a bearing race, and the spoke support tubes 177 aligned with the longitudinal slots 180. The swing arms 176 and longitudinal slots 180 confine the movement of the spokes 42 to a radial direction in a plane through the longitudinal axis of the secon~ section 174 and inhibit lateral movement of the spokes 42 out of the plane. The distal end of the first tubular section 173 is then abutted against the proximal end of the second tubular section 174 thereby capturing the ball bearings 178 within the bearing race ~Loove 182 to hold the swing arms 176 in place. The first ~llh~ r section 173 is attached to the second tubular section 174 by glue, epoxy, laser welding, or any other suitable means.
Ends of the spokes 42 are then inserted into the spoke WO96/09013 2 2 0 ~ 4 C, PCT~S95/10931 s~rpQrt tubes 177 and are held in place by epoxy, glue, laser welding, or any other suitable means.
As depicted in Fig. 17, the frustaconical tip 145 of the catheter for use in conjunction with the h~lching 143 shown in Fig. 16 is fabricated from a first section 160 of brass having a cylindrical section terminating in a frustaconical point and an ~ abutting second generally cylindrical section 161 of brass. The two sections 160 and 161 have outer diameters of 0.138~ (3.5 mm), and inner diameters of 0.042H (1.079 mm) and an overall combined length of .335~ (8. 5 mm). An inner bore 155 extends through the second section 161 and into the first section 160.
The inner bore 155 of the tubular sections 160 and 161 is sized and chApe~ to accommodate the distal end of the guidewire 44 and to prevent the tip 145 from rotating around the guidewire 44. The second section 161 of the tip 145 iS identical to the second section 174 of the hl~C~ing 143. As with the hll~hing 143, a series of swing arms 176, having spoke support tubes 177 attached to ball bearings 178, serve as hinges and are disposed with the ball bearings 178 positioned within the circular groove 182 serving as a bearing race and the spoke ~ OI L tubes 177 aligned with the longitl~inAl slots 180. The swing arms 176 and the longit~inAl slots 180 confine the movement of the spokes 42 to a radial direction in a plane through the longit~inAl axis of the second section 174 and inhibit lateral movement of the spokes 42 out of the plane. The proximate end of the first section 160 is then abutted against the distal end of the second section 161 thereby holding the swing arms 176 in place. The first section 160 iS secured to the second section 161 by glue, epoxy, laser welding, or any 22304~
W096/09013 PCT~S95/10931 other suitable means. The free ends of spokes 42 can then be inserted into the spoke support tubes 177 where they are releasably held in place.
In still another embodiment, the bushing and a proximate section of a frustaconical tip may be made from a tl~hlllA~ section 274 of flexible plastic or metal, as depicted in Figs. l9a and l9b, to guide the movement of spokes 42. One end of the tubular section 274 is fluted with each flute 276 being sufficiently wide to prevent movement of the spokes 42 out of a plane through the longitllAin~l axis of the tubular section 274 and the longitllAin~l axis of the flute 276. The fixed ends of the spokes 42 are attached to the separated flutes 276 of the tubular section 274 used as the hllching by epoxy, glue, laser welding, or any other suitable means. The free ends of the spokes 42 may be releasably held in the flutes 276 of the tllhlll ar section 274 used in the frustaconical tip. When the hllching is moved longitllAinAlly relative to the frustaconical tip by the drive unit 48 so as to shorten the distance between the h~lC~ing and the tip, the spokes 42 and the flutes 276 flex as shown in Fig. l9b. When the hllc~ing is returned to its starting position relative to the tip, the spokes 42 and the flutes 276 return to their unflexed positions as shown in Fig. l9a.
As shown in Fig. 14, a stent 10 is depicted that is substantially similar to the stent shown in Fig. 1 except that the component parts of the stent lO
shown in Fig. 14 have different sizes relative to one another. For example, the coupling tubes 18 shown in Fig. 14 are somewhat oversized relative to the stent shown in Fig. 1. Also, the connecting links 16 shown 2200~oS
wog6/oso13 PCT~S95/10931 in Fig. 14 are somewhat more ro~ln~A than the ~onnecting links ~hown in Fig. l. While the stent shown in Fig. 14 is presently a preferred - configuration, both stents function in a similar manner.
In operation, a method of deploying the stent lO is shown in Figs. lOa-d. Referring to Fig.
lOa, the stent l0 is first installed on the stent deployment mech~nicm 40. The spokes 42 are passed through the coupling tubes 18 with the guidewire 44 passing through the lumen of stent l0. If a vein segment is attached to the stent in the manner shown in Fig. 5, the spokec must poke through the portions of the vein segments that cover the openings to the coupling tubes 18. After the stent is properly positioned on the stent deployment mechanism 40, the free ends of the spokes 42 are manually nested within the tip 45 as shown in Fig. lOb. The outer sheath 46 is then slid over the stent l0 to cover stent lO. The tip 45 at the distal end of stent deployment mech~nism 40 is then inserted into the body and moved to the target location within the body passage. The outer sheath 46 is then pulled back to expose the stent lO and the stent deployment mechAn;sm 40 at the target location. The drive unit 48 is then actuated to displace tip 45 in a direction toward the bushing 43 at the end of flexible tube 41 causing the spokes 42 to flex radially outward thereby exerting an external, radially outward force that expands the stent lO as shown in Fig. lOc. Once the stent l0 is pAn~e~ to the desired diameter, plastic deformation of the connecting links causes the stent to remain in its eYpAn~ed configuration providing a radially enlarged central lumen. After the stent has been 2200lt89 WO96/09013 PCT~S95/10931 ~Yr~n~eA, the tip 45 is displaced by the drive unit in a direction away from the hllchin~ 43 at the distal end of flexible tube 41 thereby releasing the free ends of the rrokes 42 from the tip 45 as shown in Fig. lOd.
The guidewire 44, the flexible tube 41, and the outer sheath 46 are then withdrawn while leaving the stent lO in position within the body passage.
~Y~mples Exam~le 1 A stent of the type shown in Fig. 2 was tested by implantation in the left external iliac artery of mongrel dogs. The stent was tested for structural integrity, deformability, migration, and patency.
Five adult male mongrel dogs were used for the study. The animals were placed under general inh~lational anesthesia with a halothane/oxygen mixture, and administered an intravenous dose of a preoperative cephalosporin. Both groins were shaved and prepped with bet~ine and alcohol prior to being draped in the usual sterile fashion. Incisions measuring approximately 2-3 cm were made vertically overlying the femoral vessels. The femoral artery was isolated and controlled with vessel loops. At this time, intravenous heparin was administered at a dose of 100 u/kg. A transverse arteriotomy was made and a 12 ft. (3.66 m) sheath introduced within the artery.
A stent according to the present invention was mounted on a 0.315" (8 mm) diameter balloon (1.57" (4 cm) in length) which was attached to the end of a catheter.
The stent was positioned in the left external iliac artery (approximately 1.97" (5 cm) from the aortic WO96/09013 2 2 0 a ~ s, PCT~S95110931 bifurcation) under fluo~-coric guidance. The stent was then eYpAn~ by inflating the balloon uniformly to lO atmocr~es. Upon completion of the procedure, an arteriogram was performed. The femoral artery was ligated and the incision closed.
After a six week convalescent period, a final arteriogram was performed via a left brachial artery approach. The gradient of pressure across the stent was then Assr~,s~ with measurements that were taken just distal to the stent, within the center of the stent and just proximal to the stent. All measurements were also compared with a baseline pressure value within the aorta near its bifurcation.
The aorta was then cannulated for the purpose of pressure-perfusion fixation of the iliac vessel with a 2% paraformaldehyde mixture. The stent was subsequently harvested within the vessel and submitted for emhe~ing in methyl methacrylate for future sectioning and histologic analysis.
The results indicate that the stent of the present invention is deployable using a balloon mounted to a catheter and that the stent was patent at the completion of the study. Also, there was no indication of migration or deformation of the stent by arteriographic analysis. Further, there was no gross evidence of exaggerated neointimal hyperplasia in any area of the stent lumen or any pressure gradient (defined as a change greater than or equal to 15% of the systolic blood pressure).
Example 2 A vein-lined stent, of the type as shown in Fig. 5, was subjected to conditions of high flow and 22'~0489 wos6/09ol3 PCT~S95/10931 high pressure in a bench top flow system to evaluate the effectiveness of a vein-lined stent.
A superficial femoral vein was harvested from a dog using stAn~rd sterile techniques. A
segment measuring approximately 0.79 in. (2 cm) in length was selected without branches and immersed in normal saline. The vein was mounted on a moistened 14Fr dilator with care being taken not to injure the endothelial surface. The stent was then slid over the lo vein segment. After slightly crimping the stent onto the external surface of the vein, the ends of the vein were everted and Se~r ed to the adventitia with interrupted 7.0 proline sutures between each stent spacer. The stent-vein assembly was mounted onto an 0.315" (8 mm) balloon catheter and deployed within a transparent and compliant elastomeric tube that simulated a vessel. The entire apparatus was then subjected to a continuous flow of isotonic saline at pressures between 15 and 200 mmHg.
Qualitative observation of the stent-vein assembly in the continuous flow field showed that even under high pressure, there was no flow around the outside of the stent. The excellent seal made by the stent-vein assembly against the vessel wall was due primarily to the eversion of the ends of the vein over the stent. The seal was evi~nce~ by micro bubbles which remained stationary on the outer ~urface of the stent in the flow field. The vein remained taut and stationary over the stent and there was no indication of stent or tissue migration.
WO96/09013 2 2 o ~ A ~ ? PCT~S95/10931 FY~m~le 3 The bulk ela~tic behavior of the stent of the type shown in Fig. 2 was evaluated by mounting the stent within a compliant tube and subjecting the stent to increasing external pressures. The luminal area of the stent was recorded at each pressure. Pressure was then plotted against area reduction to estimate the stiffne66, or inversely, the compliance of the stent.
The apparatus for loading the stent essentially comprised a compliant vessel with an inner diameter of 0.315" (8 mm), a pressure chamber for housing the vessel and the stent, a pressure transducer, and a video camera. The compliant tubes were custom manufactured using Dow Corning Sylgard 184. A very thin layer (approximately 0.016"
(0.4 mm)) of the material was applied in liquid state to a polished 0.315" (8 mm) diameter cylinder mandrel which was constantly rotating in an oven at 150~C.
The application of the liquid Sylgard to the mandrel was carefully controlled to insure that the thickness of the tubes did not vary around the circumference or the length of the tubes. The tubes were removed from the mandrel after curing and then mounted in the pressure chamber. The stent was then mounted on a balloon catheter (0.315" (8 mm) O.D.) and expanded within the lumen of the tube. The compliant tube section cont~ining the stent was supported from both ends by rigid plexiglass fittings. The tube lumen was open to atmospheric pressure while the pressure chamber represented the external environment of the compliant tube. This configuration ensured that only the stented segment deformed under pressure. Two additional ports in the pressure chamber served as 220C!l ~?
WO96/09013 PCT~S95/10931 access for the pressure transducer and the syringe for imparting pressure to the system.
After the pressure chamber was filled with water, a syringe was connected to the system. The pressure within the system was controlled by the syringe piston displacement and monitored by the pressure trAnC~l~cer. A video camera was focused on the segment of tube containing the stent. Pressure within the chamber was increased from atmospheric pressure in 500 pascal increments. At each incremental increase in the chamber pressure, a personal computer digitized the video frame of interest. This image was ported to an image processing program where the luminal area was measured. The test was stopped when the luminal area measurement had decreased by lO mm2. In order to determine stent compliance, the change in the stent cross-sectional area was plotted against the incremental pressure increases. Compliance C was estimated from the relation:
C= (A2 - A~)/(P2 - Pl) where (A2 - A~) is the incremental area change and (P2 ~
P~) is the incremental pressure change. Stiffness is defined as the inverse of compliance. It should be noted from this relation that compliance is in~p~n~ent of the stent length. The stent of the present invention showed an initially linear elastic behavior up to approximately lO.0 KPa. Between lO.O KPa and 20.0 KPa, the stent began to deform more for the same incremental increase in pressure. This pressure-deformation behavior indicated that the yield point of the material had been reached and that the WO96/09013 2 2 0 û 4 ~ ~ PCT~S95/10931 stent was deforming plastically rather than elastically. A linear regression was applied to the data points up to lO.0 KPa in order to determine the compliance of the stent in the elastic region of deformation. The slope of the regression fit represents the bulk stiffness and the inverse of this slope represents the compliance. This analysis yielded a ~tiffne~s of 5221.65 and a compliance of 0.0002. The significance of such a low compliance is that increased rigidity is considered desirable in a stent.
In summary, the above Examples indicate that a stent according to the present invention can be ~Yp~n~ed within the lumen of a body passage and can be lS used to sup~o~ an endothelial layer. As such, the stent should improve vascular patency rates in current applications for stents, such as obliterative disease, arteriovenous fistulas, intimal injuries, and aneurysmal ~ Q. The stent should also reduce thrombogenesis and neointimal hyperplasia. The stent should also counteract recoil of the vessel wall following angioplasty. In addition, the stent may be deployed by the stent delivery apparatus that couples to the stent and exerts an outward force on the external surface of the stent thereby leaving the luminal environment of the stent undisturbed.
The delivery apparatus 8 is designed specifically for the deployment of the stent lO.
However, the wire cage or basket of the delivery apparatus could be easily adapted for transcatheter extraction of urinary tract and biliary tract stones or for retrieval of intravascular foreign bodies. The wire cage of the delivery apparatus actively expands 2~ o ~ ~ o ~ ~
WO96/09013 PCT~S95/10931 and tends to passively collapse. Additionally, the delivery apparatus of the ~ ~-ent invention might also be modified to incorporate a high speed rotary device within the wire cage. The delivery apparatus could then be used for declotting prosthetic dialysis access grafts, central veins, or even pulmonary arteries.
It will be ~ o-~..ized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intenAe~ to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.
In a particular emho~iment~ the stent 10 is fabricated from a single piece of continuous tube with no welds or solder points. For example, a 316L grade seamless stainless steel tube with an outer diameter of 0.125" (3.175 mm), a nominal wall thickness of 0.006" (0.1524 mm), and an overall length of 0.5"
(12.7 mm) may be used. Six rectangular regions of material are removed from each end of the tube so that material remains for six rigid support tabs 15. The ~u~G~ L tabs are thin, generally arcuate, and conform in shape to the stent in the first direction.
Deformable ronn~cting links 16 and spacer bars 17 are formed by removing six generally H-sh~pe~ regions 11 from the central portion of the tube thereby forming open areas in the tubular stent. Thus, the stent 10 has a general tubular structure having a thin-walled 22 JO$~S
WO96/09013 PCT~S95/10931 lattice frame with sren;ngs in the frame. Wire electrical A i~~h~rge mac~ini ng or wire EDM can be used for removing sections of the tubing to extremely high precision without creating burrs or deformations. The wire diameter for cutting can be approximately 0.010"
(0.254 mm) resulting in corners that are radiused to 0.005" (0.127 mm). Using this method a stent 10 can be made with rigid D~G~L tabs 15 that are 0.0625"
(1.588 mm) long by 0.0625" (1.588 mm) wide, spacer bars 17 that are 0.374" (9.5 mm) long by 0.020"
(0.508 mm) wide and connecting links 16 that are 0.004" (0.102 mm) wide relative to the circumference of the stent. After full ~yp~ncion~ the stent 10 can assume a final diameter of approximately 0.315"
(8.0 mm) or 2.5 times its original diameter.
The total intimal surface area along a stented segment of a vessel can be approximated from the equation for the surface area of a tube, or ~dl, where d is the stent diameter and l is the stent length. For a stented region corresponding to the stent 10 of the type shown schematically in Fig. 3 with the above dimensions, the estimated total intimal surface area is ~(8.0)(12.7)= 319.20 mm2. The total surface area of the stent, with coupling tubes made from 26 gauge hypodermic tubing, that can be exposed to the vessel lumen is estimated to be 99.02 mm2.
Using geometrical constraints, the area of metallic surface in contact with intimal tissue is estimated to be 54.43 mm2. Expressed in terms of percent open area within the stented segment, the stent of the present invention is therefore estimated to be 82.95~ open.
This result suggests that the stent of the present invention is capable of preserving a large area of endothelialized tissue. In addition, the amount of WO96/09013 2 2 IJ O ~ '~ ', PCT~S95/10931 metallic surface ~YrQ~~~ to the blood is kept relatively low.
Construction of the stent lO is not limited to ~tainle~s steel. The ~tent lO can be made from any material which is compatible with the human body and any bodily fluids that the stent lO may contact.
However, the stent lO must be made from a material that allows for ~YrAncion of stent lO and must be able to maintain its eYrAnA~ shape while disposed within the lumen of the body passage. In addition to stainless steel, suitable materials for construction of stent lO may include tantalum and titanium. The stent lO can also be fabricated from a memory metal such as nitinol. In addition, the stent lO does not have to be fabricated from a single piece of continuous tube. For example, the spacer bars 17 and/or the connecting links 16 can be made separately from the rigid ~y~O~ tabs 15 and attached using, for example, laser welding techniques. Alternatively, the stent lO may be fabricated by extruding the stent lO
as one piece.
While the stent may be deployed as a "stand alone" device, the stent may also be effectively used as a vA~c~llAr endograft by attaching a segment of vein, preferably an autologous vein or a synthetic graft material within the central lumen of the stent.
Preferably, an autologous vein segment is utilized to provide an endothelial layer as a lining for the lumen of the stent. As shown in Figs. 4a - 4c, a vein segment 25 may be attached to the inner surface of the stent lO by, for example, using tissue adhesive 29.
As shown in Fig. 4a, the vein segment 25 is attached to a piece of tubing 26 with suture 27, which is in 221l0~J~
WO96/09013 PCT~S95110931 turn attached to a syringe filled with isotonic saline. The free end of the vein segment 25 is then closed with ~ Le 28. The vein segment 25 is deflated using the syringe and, as shown in Fig. 4b, the vein segment is then inserted into the lumen of the stent 10. A small amount of tissue adhesive 29 is applied to multiple points along the inner surface of the stent 10. As shown in Fig. 4c, the vein segment 25 is then inflated 80 that the outer surface of the vein segment 25 contacts the inner surface of stent 10 especially at the points where tissue adhesive 29 has been applied. Once the ti~sue adhesive 29 has cured, the vein segment 25 is disconnected from the tubing 26 and the eYc~ss vein segment 25 is trimmed at each end of the stent.
The use of tissue adhesive to secure the vein segment to the stent may not always be suitable or permitted. Accordingly, a vein segment may be attached to the stent 10 in accordance with a preferred method of using sutures 30. As shown in Fig. 5, a length of vein segment 25 about twice as long as the length of stent 10 is used. The vein segment 25 is inserted within the lumen of stent 10 so that the stent is generally centered about the vein segment 25. The ends of the vein segment 25 are then everted over the ends of stent 10 so as to completely line the inner surface of stent 10 and to substantially cover the outer surface of stent 10.
After slightly crimping the stent 10 onto the external surface of the vein segment 25, the proximal and distal ends of the vein segment 25 are secured to the adventitia with interrupted 7.0 proline sutures between each spacer bar 17. Accordingly, a stent-vein 2 2 3 ~J 4 ~, WO96/0~13 PCT~S95/10931 complex is provided for deployment at the target location by the stent delivery apparatus lO.
The stent delivery apparatus 8 includes a ~tent deployment mech~n~sm 40, as shown in Figs. 6 and 7, manually operated by drive unit 48, as shown in Fig. 8. The drive unit 48 (Edmund Scientific, Barrington, NJ, model ~J3650) is connected with the stent deployment mechAnifim 40 by control cable 49.
The stent deployment mechanism 40 includes a series of six spokes 42 each connected at one end to a bushing 43. The spokes 42 may be in the form of a symmetric bundle of six spring steel wires of diameter .008 inches (.203 mm) bonded to the outer wall of the htlC~ing 43 which is in the form of a 316L grade stainless steel tube having a length of approximately .25 inches (6.35 mm), an outer diameter of .0732 inches (l.86 mm) and an inner diameter of .05 inches (l.28 mm). The free ends of the spokec removably nest within conical tip 45 di~ at the end of a central guidewire 44 in the form of stainless steel wire having a diameter of .04 inc-h~s (l mm). When the guidewire 44 is moved to retract the tip 45 toward the cable 49, the free ends of the spokes can be positioned to nest within the tip 45. When the guidewire 44 is moved to displace the tip 45 away from the cable 49 the free ends of the spokes 42 are released as shown in Fig. 6.
In cable 49, the central guidewire 44 is coaxially contained within a flexible guide tube 41 in the form of a polymer tubing, such as flexible nylon tubing having the same inner and outer diameters as the h~l~hing 43. The hn~h;ng 43 is bonded to one end of the guide tube 41 using, for example, epoxy, spot WO96/09013 220a$~9 PCT~S95/10931 welding, or soldering t~chniques. The junction between the h -C~ ing 43 and the guide tube 41 is enclosed within an external junction sleeve 39 in the form of a ~tainles~ steel tube segment. The other end of the flexible guide tube extends with the guidewire 44 approximately 30 inr~eC to the drive unit 48 shown in Fig. 8. The drive unit functions to displace the guidewire 44 through the flexible guide tube 41 in a controlled manner by manual rotation of actuator knob 38. The guidewire 44 and the flexible guide tube 41 are enclosed within an outer sheath tube 46 in the form of a polymer tube such as a clear polyethylene or teflon tubing that is approximately 30 inches long.
As best shown in Figs. 1 and 6, the end of the sheath tube 46 at the stent deployment mechanism is capped by a sheath cap 47 in the form of 316L grade stainless steel tubing having a length of approximately 2 inches. The sheath cap 47 serves as a rigid housing for accommodating the wire spoke bundle 42 when the sheath cap is slid over the wire spoke bundle. The sheath tube 46 may be manually retracted relative to flexible tube 41 and guidewire 44 to displace the sheath cap 47 from the wire spoke bundle 42 in order to expose the wire spoke bundle. Flexible tube 41, guidewire 44, and outer sheath 46 are concentric and allowed to move relative to each other along their axes.
The proximal ends of flexible tube 41 and guidewire 44 are attached to the linear microdrive unit 48, which allows for the axial movement of guidewire 44 relative to flexible tube 41. As knob 38 is turned an internal rack and pinion drive mechanism longitllAin~lly displaces the central guidewire 44 relative to the flexible inner tube 41. As 22uo4a~
WO 96/OgO13 PCr/USgS/10931 schematically depicted in Fig. 9a, when the tip 45 of the guidewire 44 is positioned in its mid-position the free ends of the spokes 42 are captured within the tip 45 but the spokes remain relatively extended, or S unflexed, between the tip 45 and the hllching 43. As schematically depicted in Fig. 9b, when the guidewire 44 is deployed so the tip 45 moves toward the h ~rhing 43 at the distal end of flexible tube 41, croke~ 42 are caused to bend and flex outwardly.
In an alternative emhoAiment of the stent deployment mech~ c-m~ the spokes 42 are attached to flexible tube 41' by hlt-ch;ng 43', as depicted in Fig.
11, which serves as a hl-ching for the guidewire 44'.
The spokes 42 may be made from spring steel wires of diameter 0.008" (0.203 mm). The h~ ing 43' is a brass cylindrical section with à frustaconical end having an outer diameter of 0.138" (3.5 mm), an inner diameter of 0.042" (1.079 mm), and a length of 0.335"
(8.5 mm). An inner bore 56 is provided through the hl~hing to permit the flexible tube 41' and the guidewire 44' to pass therethrough. The cross section of the inner bore 56 of h~lching 43' is not circular but instead includes flattened sidewall sections to prevent the hllching 43' from rotating around the flexible tube 41'. The flexible tube 41' is made from ABS plastic tubing with an approximate 3" (76.2 mm) length of the distal end of the flexible tube 41' being ~peA with flattened sidewall sections to mate with inner bore 56. Six ~mall angled bores 50 are drilled at 30~ relative to the longitudinal axis of the hllching at the distal end of the bllching 43'. The bores 50 are approximately 0.010" (0.254 mm) in diameter and widen to approximately 0.020" (0.005 mm) at the periphery of the hll~ching. The bores are WO96/09013 PCT~S95/10931 substantially equally spaced around the distal end of the kl~hi~g 43~ to accommodate the spokes 42, which are epoxy glued in place within the bores 50. The b~l~hing 43' is epoxy bQn~Q~ about the distal end of the flexible tube 41'. The flexible tube 41' extends from the hllChi~ for 30" before being connected to the linear microdrive unit 48. In addition, the outer sheath 46 is constructed from teflon tubing approximately 30" (76.2 cm) in length with an inner diameter sufficiently large to form a slip fit over the bllching 43'. Attached to the distal end of the outer sheath 46 is a tubular end cap 47 which is fabricated from a 316L grade stainless steel tubing approximately 2" (50.8 mm) in length and with similar inner and outer diameters to the outer sheath 46. The end cap 47 serves as a rigid housing that accommodates spokes 42 when the spokes 42 are withdrawn sufficiently into the end cap 47.
As depicted in Figs. 12 and 13, a frustaconical tip 45' of the catheter is used in conjunction with the hl)ching 43' depicted in Fig 11.
The tip 45' is fabricated from two brass sections, 60 and 61, having outer diameters of approximately 0.138"
(3.5 mm) and inner diameters of approximately 0.042"
(1.079 mm). The first section is generally cylindrical with a frustaconical end. The second section is generally cylindrical. A central aligned bore 55 extends through the Fecon~ section and into the first section. The cross cection of the inner bores 55 of the two tubular sections 60 and 61 are not circular but instead have flattened sidewall sections, as shown in Fig. 12, to prevent the tip 45' from rotating around the guidewire 44'. The guidewire 44' is made from narrow hypodermic tubing with an 22 ~-t 8 , Wos6/o9ol3 PCT~S95/10931 approximately 3" (76.2 mm) length of the distal end of the guidewire 44' being shaped with flattened exterior sidewall sections to mate with inner bore 55. The first section 60 of the tip 45' has a length of approximately 0.236" (6 mm) and the second section 61 of the tip 45' has a length of 0.010" (2.5 mm). Six small radially oriented bore holes 51, approximately 0.020" (0.508 mm) in diameter, are drilled at 30~
angles relative to the longitl~;n~l axis of the central bore 55. The bore holes 51 are uniformly spaced around the proximal end of the first section 60 to accommodate the free ends of the spokes 42, which are loosely held in place. Small exterior longitllAinal slots 52, 0.020" (0.508 mm) deep and 0.020" (0.508 mm) wide, are milled along the second section 61 to act as guide slots for the spokes 42.
The longitllA i nA 1 slots 52 confine the movement of the spokes 42 to a radial direction in a plane through the longitllAinAl axis of the ceconA section 61 and inhibit lateral movement of the spokec 42 out of the plane.
The proximal end of the first section 60 is held by friction fit on the end of the guidewire 44' in abutment with the distal end of the second section 61, so that the slots 52 along the second section 61 register with the bore holes 51 drilled in the first section 60. Alternatively, the first section 60 and the second section 61 can be attached using epoxy or spot welding techniques.
Yet another emhoAiment of the stent deployment mechanism 40 is depicted in Figs. 15-18.
The hllching 143 is fabricated from two abutting brass sections, 173 and 174. The first section 173 has a larger cylindrical portion at the distal end that tapers into a frustaconical section which terminates 220u~
WO96/09013 PCT~S95/10931 in a smaller cylindrical section at the proximate end of the first section. The F~con~ ~ection 174 is generally cylindrical. The two abutting sections 173 and 174 have outer diameters of 0.138" (3.5 mm), inner diameters of 0.042" (1.079 mm), and a combined overall length of 0.335~ (8.5 mm). An inner bore 156 passes through both sections. The cross section of the inner bore 156 of the two t~h~ r sections 173 and 174 is sized and ~p~A to mate with the distal end of the flexible tube 41 and to prevent the bushing 143 from rotating around the flexible tube 41. The second section 174 has a circular groove 182 milled into the proximal end of the second tubular section 174. The circular groove 182 is concentric with the inner bore 156. In addition, small external longitudinal slots 180 are milled along the second tubular section 174. A series of six swing arms 176, having spoke su~olL tubes 177 attAchD~ to ball bearings 178, serve as hinges and are disposed with the ball bearings 178 positioned within the circular groove 182, which serves as a bearing race, and the spoke support tubes 177 aligned with the longitudinal slots 180. The swing arms 176 and longitudinal slots 180 confine the movement of the spokes 42 to a radial direction in a plane through the longitudinal axis of the secon~ section 174 and inhibit lateral movement of the spokes 42 out of the plane. The distal end of the first tubular section 173 is then abutted against the proximal end of the second tubular section 174 thereby capturing the ball bearings 178 within the bearing race ~Loove 182 to hold the swing arms 176 in place. The first ~llh~ r section 173 is attached to the second tubular section 174 by glue, epoxy, laser welding, or any other suitable means.
Ends of the spokes 42 are then inserted into the spoke WO96/09013 2 2 0 ~ 4 C, PCT~S95/10931 s~rpQrt tubes 177 and are held in place by epoxy, glue, laser welding, or any other suitable means.
As depicted in Fig. 17, the frustaconical tip 145 of the catheter for use in conjunction with the h~lching 143 shown in Fig. 16 is fabricated from a first section 160 of brass having a cylindrical section terminating in a frustaconical point and an ~ abutting second generally cylindrical section 161 of brass. The two sections 160 and 161 have outer diameters of 0.138~ (3.5 mm), and inner diameters of 0.042H (1.079 mm) and an overall combined length of .335~ (8. 5 mm). An inner bore 155 extends through the second section 161 and into the first section 160.
The inner bore 155 of the tubular sections 160 and 161 is sized and chApe~ to accommodate the distal end of the guidewire 44 and to prevent the tip 145 from rotating around the guidewire 44. The second section 161 of the tip 145 iS identical to the second section 174 of the hl~C~ing 143. As with the hll~hing 143, a series of swing arms 176, having spoke support tubes 177 attached to ball bearings 178, serve as hinges and are disposed with the ball bearings 178 positioned within the circular groove 182 serving as a bearing race and the spoke ~ OI L tubes 177 aligned with the longitl~inAl slots 180. The swing arms 176 and the longit~inAl slots 180 confine the movement of the spokes 42 to a radial direction in a plane through the longit~inAl axis of the second section 174 and inhibit lateral movement of the spokes 42 out of the plane. The proximate end of the first section 160 is then abutted against the distal end of the second section 161 thereby holding the swing arms 176 in place. The first section 160 iS secured to the second section 161 by glue, epoxy, laser welding, or any 22304~
W096/09013 PCT~S95/10931 other suitable means. The free ends of spokes 42 can then be inserted into the spoke support tubes 177 where they are releasably held in place.
In still another embodiment, the bushing and a proximate section of a frustaconical tip may be made from a tl~hlllA~ section 274 of flexible plastic or metal, as depicted in Figs. l9a and l9b, to guide the movement of spokes 42. One end of the tubular section 274 is fluted with each flute 276 being sufficiently wide to prevent movement of the spokes 42 out of a plane through the longitllAin~l axis of the tubular section 274 and the longitllAin~l axis of the flute 276. The fixed ends of the spokes 42 are attached to the separated flutes 276 of the tubular section 274 used as the hllching by epoxy, glue, laser welding, or any other suitable means. The free ends of the spokes 42 may be releasably held in the flutes 276 of the tllhlll ar section 274 used in the frustaconical tip. When the hllching is moved longitllAinAlly relative to the frustaconical tip by the drive unit 48 so as to shorten the distance between the h~lC~ing and the tip, the spokes 42 and the flutes 276 flex as shown in Fig. l9b. When the hllc~ing is returned to its starting position relative to the tip, the spokes 42 and the flutes 276 return to their unflexed positions as shown in Fig. l9a.
As shown in Fig. 14, a stent 10 is depicted that is substantially similar to the stent shown in Fig. 1 except that the component parts of the stent lO
shown in Fig. 14 have different sizes relative to one another. For example, the coupling tubes 18 shown in Fig. 14 are somewhat oversized relative to the stent shown in Fig. 1. Also, the connecting links 16 shown 2200~oS
wog6/oso13 PCT~S95/10931 in Fig. 14 are somewhat more ro~ln~A than the ~onnecting links ~hown in Fig. l. While the stent shown in Fig. 14 is presently a preferred - configuration, both stents function in a similar manner.
In operation, a method of deploying the stent lO is shown in Figs. lOa-d. Referring to Fig.
lOa, the stent l0 is first installed on the stent deployment mech~nicm 40. The spokes 42 are passed through the coupling tubes 18 with the guidewire 44 passing through the lumen of stent l0. If a vein segment is attached to the stent in the manner shown in Fig. 5, the spokec must poke through the portions of the vein segments that cover the openings to the coupling tubes 18. After the stent is properly positioned on the stent deployment mechanism 40, the free ends of the spokes 42 are manually nested within the tip 45 as shown in Fig. lOb. The outer sheath 46 is then slid over the stent l0 to cover stent lO. The tip 45 at the distal end of stent deployment mech~nism 40 is then inserted into the body and moved to the target location within the body passage. The outer sheath 46 is then pulled back to expose the stent lO and the stent deployment mechAn;sm 40 at the target location. The drive unit 48 is then actuated to displace tip 45 in a direction toward the bushing 43 at the end of flexible tube 41 causing the spokes 42 to flex radially outward thereby exerting an external, radially outward force that expands the stent lO as shown in Fig. lOc. Once the stent l0 is pAn~e~ to the desired diameter, plastic deformation of the connecting links causes the stent to remain in its eYpAn~ed configuration providing a radially enlarged central lumen. After the stent has been 2200lt89 WO96/09013 PCT~S95/10931 ~Yr~n~eA, the tip 45 is displaced by the drive unit in a direction away from the hllchin~ 43 at the distal end of flexible tube 41 thereby releasing the free ends of the rrokes 42 from the tip 45 as shown in Fig. lOd.
The guidewire 44, the flexible tube 41, and the outer sheath 46 are then withdrawn while leaving the stent lO in position within the body passage.
~Y~mples Exam~le 1 A stent of the type shown in Fig. 2 was tested by implantation in the left external iliac artery of mongrel dogs. The stent was tested for structural integrity, deformability, migration, and patency.
Five adult male mongrel dogs were used for the study. The animals were placed under general inh~lational anesthesia with a halothane/oxygen mixture, and administered an intravenous dose of a preoperative cephalosporin. Both groins were shaved and prepped with bet~ine and alcohol prior to being draped in the usual sterile fashion. Incisions measuring approximately 2-3 cm were made vertically overlying the femoral vessels. The femoral artery was isolated and controlled with vessel loops. At this time, intravenous heparin was administered at a dose of 100 u/kg. A transverse arteriotomy was made and a 12 ft. (3.66 m) sheath introduced within the artery.
A stent according to the present invention was mounted on a 0.315" (8 mm) diameter balloon (1.57" (4 cm) in length) which was attached to the end of a catheter.
The stent was positioned in the left external iliac artery (approximately 1.97" (5 cm) from the aortic WO96/09013 2 2 0 a ~ s, PCT~S95110931 bifurcation) under fluo~-coric guidance. The stent was then eYpAn~ by inflating the balloon uniformly to lO atmocr~es. Upon completion of the procedure, an arteriogram was performed. The femoral artery was ligated and the incision closed.
After a six week convalescent period, a final arteriogram was performed via a left brachial artery approach. The gradient of pressure across the stent was then Assr~,s~ with measurements that were taken just distal to the stent, within the center of the stent and just proximal to the stent. All measurements were also compared with a baseline pressure value within the aorta near its bifurcation.
The aorta was then cannulated for the purpose of pressure-perfusion fixation of the iliac vessel with a 2% paraformaldehyde mixture. The stent was subsequently harvested within the vessel and submitted for emhe~ing in methyl methacrylate for future sectioning and histologic analysis.
The results indicate that the stent of the present invention is deployable using a balloon mounted to a catheter and that the stent was patent at the completion of the study. Also, there was no indication of migration or deformation of the stent by arteriographic analysis. Further, there was no gross evidence of exaggerated neointimal hyperplasia in any area of the stent lumen or any pressure gradient (defined as a change greater than or equal to 15% of the systolic blood pressure).
Example 2 A vein-lined stent, of the type as shown in Fig. 5, was subjected to conditions of high flow and 22'~0489 wos6/09ol3 PCT~S95/10931 high pressure in a bench top flow system to evaluate the effectiveness of a vein-lined stent.
A superficial femoral vein was harvested from a dog using stAn~rd sterile techniques. A
segment measuring approximately 0.79 in. (2 cm) in length was selected without branches and immersed in normal saline. The vein was mounted on a moistened 14Fr dilator with care being taken not to injure the endothelial surface. The stent was then slid over the lo vein segment. After slightly crimping the stent onto the external surface of the vein, the ends of the vein were everted and Se~r ed to the adventitia with interrupted 7.0 proline sutures between each stent spacer. The stent-vein assembly was mounted onto an 0.315" (8 mm) balloon catheter and deployed within a transparent and compliant elastomeric tube that simulated a vessel. The entire apparatus was then subjected to a continuous flow of isotonic saline at pressures between 15 and 200 mmHg.
Qualitative observation of the stent-vein assembly in the continuous flow field showed that even under high pressure, there was no flow around the outside of the stent. The excellent seal made by the stent-vein assembly against the vessel wall was due primarily to the eversion of the ends of the vein over the stent. The seal was evi~nce~ by micro bubbles which remained stationary on the outer ~urface of the stent in the flow field. The vein remained taut and stationary over the stent and there was no indication of stent or tissue migration.
WO96/09013 2 2 o ~ A ~ ? PCT~S95/10931 FY~m~le 3 The bulk ela~tic behavior of the stent of the type shown in Fig. 2 was evaluated by mounting the stent within a compliant tube and subjecting the stent to increasing external pressures. The luminal area of the stent was recorded at each pressure. Pressure was then plotted against area reduction to estimate the stiffne66, or inversely, the compliance of the stent.
The apparatus for loading the stent essentially comprised a compliant vessel with an inner diameter of 0.315" (8 mm), a pressure chamber for housing the vessel and the stent, a pressure transducer, and a video camera. The compliant tubes were custom manufactured using Dow Corning Sylgard 184. A very thin layer (approximately 0.016"
(0.4 mm)) of the material was applied in liquid state to a polished 0.315" (8 mm) diameter cylinder mandrel which was constantly rotating in an oven at 150~C.
The application of the liquid Sylgard to the mandrel was carefully controlled to insure that the thickness of the tubes did not vary around the circumference or the length of the tubes. The tubes were removed from the mandrel after curing and then mounted in the pressure chamber. The stent was then mounted on a balloon catheter (0.315" (8 mm) O.D.) and expanded within the lumen of the tube. The compliant tube section cont~ining the stent was supported from both ends by rigid plexiglass fittings. The tube lumen was open to atmospheric pressure while the pressure chamber represented the external environment of the compliant tube. This configuration ensured that only the stented segment deformed under pressure. Two additional ports in the pressure chamber served as 220C!l ~?
WO96/09013 PCT~S95/10931 access for the pressure transducer and the syringe for imparting pressure to the system.
After the pressure chamber was filled with water, a syringe was connected to the system. The pressure within the system was controlled by the syringe piston displacement and monitored by the pressure trAnC~l~cer. A video camera was focused on the segment of tube containing the stent. Pressure within the chamber was increased from atmospheric pressure in 500 pascal increments. At each incremental increase in the chamber pressure, a personal computer digitized the video frame of interest. This image was ported to an image processing program where the luminal area was measured. The test was stopped when the luminal area measurement had decreased by lO mm2. In order to determine stent compliance, the change in the stent cross-sectional area was plotted against the incremental pressure increases. Compliance C was estimated from the relation:
C= (A2 - A~)/(P2 - Pl) where (A2 - A~) is the incremental area change and (P2 ~
P~) is the incremental pressure change. Stiffness is defined as the inverse of compliance. It should be noted from this relation that compliance is in~p~n~ent of the stent length. The stent of the present invention showed an initially linear elastic behavior up to approximately lO.0 KPa. Between lO.O KPa and 20.0 KPa, the stent began to deform more for the same incremental increase in pressure. This pressure-deformation behavior indicated that the yield point of the material had been reached and that the WO96/09013 2 2 0 û 4 ~ ~ PCT~S95/10931 stent was deforming plastically rather than elastically. A linear regression was applied to the data points up to lO.0 KPa in order to determine the compliance of the stent in the elastic region of deformation. The slope of the regression fit represents the bulk stiffness and the inverse of this slope represents the compliance. This analysis yielded a ~tiffne~s of 5221.65 and a compliance of 0.0002. The significance of such a low compliance is that increased rigidity is considered desirable in a stent.
In summary, the above Examples indicate that a stent according to the present invention can be ~Yp~n~ed within the lumen of a body passage and can be lS used to sup~o~ an endothelial layer. As such, the stent should improve vascular patency rates in current applications for stents, such as obliterative disease, arteriovenous fistulas, intimal injuries, and aneurysmal ~ Q. The stent should also reduce thrombogenesis and neointimal hyperplasia. The stent should also counteract recoil of the vessel wall following angioplasty. In addition, the stent may be deployed by the stent delivery apparatus that couples to the stent and exerts an outward force on the external surface of the stent thereby leaving the luminal environment of the stent undisturbed.
The delivery apparatus 8 is designed specifically for the deployment of the stent lO.
However, the wire cage or basket of the delivery apparatus could be easily adapted for transcatheter extraction of urinary tract and biliary tract stones or for retrieval of intravascular foreign bodies. The wire cage of the delivery apparatus actively expands 2~ o ~ ~ o ~ ~
WO96/09013 PCT~S95/10931 and tends to passively collapse. Additionally, the delivery apparatus of the ~ ~-ent invention might also be modified to incorporate a high speed rotary device within the wire cage. The delivery apparatus could then be used for declotting prosthetic dialysis access grafts, central veins, or even pulmonary arteries.
It will be ~ o-~..ized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intenAe~ to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.
Claims (85)
1. An expandable, generally tubular, intraluminal stent comprising:
a) a plurality of rigid end supports disposed in a ring at each end of the tubular stent;
b) a plurality of rigid struts for connecting the ring of end supports at one end of the stent with the ring of end supports at the other end of the stent to inhibit relative longitudinal displacement between end supports at opposite ends of the stent; and c) a plurality of deformable connecting links linking adjacent end supports in each respective ring so that the stent may be radially expanded from a first smaller diameter to a second larger diameter.
a) a plurality of rigid end supports disposed in a ring at each end of the tubular stent;
b) a plurality of rigid struts for connecting the ring of end supports at one end of the stent with the ring of end supports at the other end of the stent to inhibit relative longitudinal displacement between end supports at opposite ends of the stent; and c) a plurality of deformable connecting links linking adjacent end supports in each respective ring so that the stent may be radially expanded from a first smaller diameter to a second larger diameter.
2. The stent in accordance with claim 1 wherein said struts include rigid spacer bars having a first end connected with a rigid end support at one end of the stent and a second end connected with a rigid end support at the other end of the stent.
3. The stent in accordance with claim 1 wherein the rigid end supports are disposed in the respective ring so that each end support is positioned diametrically opposed to another one of the end supports in the ring.
4. The stent in accordance with claim 1 wherein all of the rigid end supports in a respective ring are linked together by said deformable connecting links.
5. The stent in accordance with claim 1 wherein all of the rigid end supports in one of the rings are connected with corresponding end supports in the other ring by the rigid struts.
6. The stent in accordance with claim 5 wherein all of the rigid end supports in a respective ring are linked together by said deformable connecting links.
7. The stent in accordance with claim 1 comprising external expansion couplings mounted to an exterior surface of the stent to enable the stent to be radially expanded from the exterior of the stent.
8. The stent in accordance with claim 7 wherein the stent includes a central lumen and a vein segment lining the central lumen of the stent.
9. The stent in accordance with claim 8 wherein the vein segment is longer than the stent and ends of the vein segment are everted over the exterior of the stent.
10. The stent in accordance with claim 7 wherein the external expansion couplings include coupling tubes mounted to the exterior of the stent with the coupling tubes extending in a longitudinal direction of the stent.
11. The stent in accordance with claim 10 wherein the coupling tubes are fixed to the struts.
12. The stent in accordance with claim 1 wherein the end supports include thin, generally arcuate support tabs.
13. The stent in accordance with claim 12 wherein the arcuate support tabs conform in shape to the stent when in the first diameter.
14. The stent in accordance with claim 13 wherein each ring includes six support tabs.
15. The stent in accordance with claim 1 wherein the deformable connecting links link adjacent end supports in each respective ring and the rigid struts connect end supports at one end of the stent to corresponding end supports at the other end of the stent so that open areas are formed in the tubular stent between a pair of adjacent end supports and a respective connecting link at one end of the stent and a pair of adjacent end supports and a respective connecting link at the other end of the stent and between a pair of adjacent struts connecting the pair of end supports at the one end of the stent to the corresponding pair of end supports at the other end of the stent.
16. The stent in accordance with claim 1 wherein the deformable connecting links link adjacent end supports in each respective ring and the rigid struts connect end supports at one end of the stent to corresponding end supports at the other end of the stent so that open areas are formed in the tubular stent between the ring of end supports and connecting links at one end of the stent and the end supports and connecting links at the other end of the stent and between adjacent rigid struts connecting the ring of end supports at the one end of the stent with the ring of end supports at the other end of the stent.
17. The stent in accordance with claim 16 wherein each of the open areas extends generally from one end of the stent to the other end of the stent when in the second enlarged diameter.
18. The stent in accordance with claim 16 wherein the open areas extend at least over half the longitudinal length of the stent.
19. The stent in accordance with claim 1 wherein the surface area of the tubular stent is at least 70%
open.
open.
20. The stent in accordance with claim 19 wherein the surface area of the stent is at least 80%
open.
open.
21. An expandable stent comprising:
a) a generally thin-walled, tubular structure having a central lumen, the tubular structure having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter for retaining the tubular structure in the lumen of the body passageway upon application of an outward radial force on the tubular structure; and b) external expansion couplings mounted on an exterior surface of the tubular structure for enabling the outward radial force to be applied externally of the tubular structure via the external expansion couplings.
a) a generally thin-walled, tubular structure having a central lumen, the tubular structure having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter for retaining the tubular structure in the lumen of the body passageway upon application of an outward radial force on the tubular structure; and b) external expansion couplings mounted on an exterior surface of the tubular structure for enabling the outward radial force to be applied externally of the tubular structure via the external expansion couplings.
22. The stent in accordance with claim 21 wherein the external expansion couplings include coupling tubes mounted to the exterior of the stent with the coupling tubes extending generally in the longitudinal direction of the stent.
23. An expandable, intraluminal, vascular graft comprising:
a) a stent having a generally thin-walled, tubular structure with a central lumen, the tubular structure having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter upon application of an outward radial force on the tubular structure for retaining the tubular structure in the lumen of the body passageway, and external expansion couplings mounted on an exterior surface of the tubular structure for enabling the outward radial force to be applied externally of the tubular structure via the external expansion couplings; and b) an endothelial layer lining the central lumen of the stent.
a) a stent having a generally thin-walled, tubular structure with a central lumen, the tubular structure having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter upon application of an outward radial force on the tubular structure for retaining the tubular structure in the lumen of the body passageway, and external expansion couplings mounted on an exterior surface of the tubular structure for enabling the outward radial force to be applied externally of the tubular structure via the external expansion couplings; and b) an endothelial layer lining the central lumen of the stent.
24. The graft in accordance with claim 23 wherein the endothelial layer includes a vein segment.
25. The graft in accordance with claim 24 wherein the vein segment is longer than the stent and ends of the vein segment are everted over ends of the stent.
26. An expandable intraluminal stent comprising a generally thin-walled tubular structure having first and second ends and a central lumen, the tubular structure having a thin-walled lattice frame with openings in the frame, the openings extending longitudinally at least half the length of the tubular structure, the tubular structure being deformable from a first smaller diameter into a second enlarged diameter.
27. The stent in accordance with claim 26 wherein the lattice frame is configured so that at least some of the openings extend generally from the first end to the second end of the stent.
28. The stent in accordance with claim 27 wherein the lattice frame is configured so that all of the openings extend generally from the first end to the second end of the stent.
29. The stent in accordance with claim 26 wherein the tubular structure includes rigid components and deformable components interconnecting the rigid components, the deformable components deforming to enable the tubular structure to expand from the first smaller diameter into the second larger diameter.
30. The stent in accordance with claim 29 wherein the rigid components include a plurality of rigid end supports disposed in a ring at each end of the tubular stent, the end supports in each ring being generally uniformly spaced apart around each respective ring.
31. The stent in accordance with claim 30 wherein the rigid components include a plurality of rigid struts for connecting the ring of end supports at one end of the stent with the ring of end supports at the other end of the stent to inhibit relative longitudinal displacement between the rings of end supports at opposite ends of the stent.
32. The stent in accordance with claim 31 wherein each strut extends generally from a respective one of the end supports at one end of the stent to a corresponding end support at the other end of the stent.
33. The stent in accordance with claim 30 wherein the deformable components include deformable connecting links linking adjacent end supports in each respective ring so that the stent may be radially expanded from the first smaller diameter to the second enlarged diameter.
34. An expandable, generally tubular, intraluminal stent comprising:
a) a plurality of rigid end supports disposed in a ring at each end of the tubular stent, the end supports in each ring being generally uniformly spaced apart around each respective ring;
b) a plurality of rigid struts for connecting the ring of end supports at one end of the stent with the ring of end supports at the other end of the stent, each strut extending generally from a respective one of the end supports at one end of the stent to a corresponding end support at the other end of the stent to inhibit relative longitudinal displacement between corresponding end supports at opposite ends of the stent; and c) a plurality of deformable connecting links linking adjacent end supports in each respective ring so that the stent may be radially expanded from a first smaller diameter enabling delivery of the stent into a selected body passageway having a lumen into a second enlarged diameter for positioning the stent in the lumen of the body passageway.
a) a plurality of rigid end supports disposed in a ring at each end of the tubular stent, the end supports in each ring being generally uniformly spaced apart around each respective ring;
b) a plurality of rigid struts for connecting the ring of end supports at one end of the stent with the ring of end supports at the other end of the stent, each strut extending generally from a respective one of the end supports at one end of the stent to a corresponding end support at the other end of the stent to inhibit relative longitudinal displacement between corresponding end supports at opposite ends of the stent; and c) a plurality of deformable connecting links linking adjacent end supports in each respective ring so that the stent may be radially expanded from a first smaller diameter enabling delivery of the stent into a selected body passageway having a lumen into a second enlarged diameter for positioning the stent in the lumen of the body passageway.
35. The stent in accordance with claim 34 wherein said struts include rigid spacer bars having a first end connected with a rigid end support at one end of the stent and a second end connected with a rigid end support at the other end of the stent.
36. The stent in accordance with claim 34 wherein the rigid end supports are disposed in the respective ring so that each end support is positioned diametrically opposed to another one of the end supports in the ring.
37. The stent in accordance with claim 34 wherein all of the rigid end supports in a respective ring are linked together by said deformable connecting links.
38. The stent in accordance with claim 34 wherein all of the rigid end supports in one of the rings are connected with corresponding end supports in the other ring by the rigid struts.
39. The stent in accordance with claim 34 comprising external expansion couplings mounted to an exterior surface of the stent to enable the stent to be radially expanded from the exterior of the stent.
40. The stent in accordance with claim 39 wherein the expansion couplings include coupling tubes mounted to the exterior of the stent.
41. The stent in accordance with claim 39 wherein the stent includes a central lumen and a vein segment lining the central lumen of the stent.
42. The stent in accordance with claim 41 wherein the vein segment is longer than the stent and ends of the vein segment are everted over ends of the stent.
43. The stent in accordance with claim 39 wherein the external expansion couplings include coupling tubes mounted to the exterior of the stent with the coupling tubes extending in a longitudinal direction of the stent.
44. The stent in accordance with claim 34 wherein the end supports include thin, generally arcuate support tabs.
45. The stent in accordance with claim 34 wherein the deformable connecting links link adjacent end supports in each respective ring and the rigid struts connect end supports at one end of the stent to corresponding end supports at the other end of the stent so that open areas are formed in the tubular stent between the ring of end supports and connecting links at one end of the stent and the end supports and connecting links at the other end of the stent and between adjacent rigid struts connecting the end supports at the one end of the stent with the end supports at the other end of the stent.
46. The stent in accordance with claim 45 wherein each of the open areas extends generally from one end of the stent to the other end of the stent when in the second enlarged diameter.
47. The stent in accordance with claim 45 wherein the open areas extend at least over half the longitudinal length of the stent.
48. An expandable stent comprising a generally thin-walled, tubular structure having a central lumen, the tubular structure having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter for retaining the tubular structure in the lumen of the body passageway, the tubular structure having rigid, non-deformable components and deformable components interconnecting the rigid components, the deformable components deforming upon radial expansion of the tubular structure to the second enlarged diameter.
49. The stent in accordance with claim 48 wherein the surface area of the rigid components exceeds the surface area of the deformable components.
50. The stent in accordance with claim 48 wherein the deformable components are disposed generally only at both ends of the tubular structure.
51. A method of deploying a stent within a selected body passage comprising the steps of:
a) providing a thin-walled, expandable, generally tubular stent with a central lumen and an exterior surface, the stent having a first smaller diameter and a second enlarged diameter in expanded configuration;
b) removably mounting the stent on a catheter;
c) inserting the stent and catheter within the selected body passageway; and d) applying an external outward radial force from the exterior surface of the stent to expand the stent from the first diameter to the enlarged second diameter at a selected location in the body passageway.
a) providing a thin-walled, expandable, generally tubular stent with a central lumen and an exterior surface, the stent having a first smaller diameter and a second enlarged diameter in expanded configuration;
b) removably mounting the stent on a catheter;
c) inserting the stent and catheter within the selected body passageway; and d) applying an external outward radial force from the exterior surface of the stent to expand the stent from the first diameter to the enlarged second diameter at a selected location in the body passageway.
52. The method in accordance with claim 51 wherein the step of removably mounting the stent on the catheter includes the step of removably coupling the catheter to the exterior surface of the stent.
53. The method in accordance with claim 51 including the step of removing the catheter from the expanded stent at the selected location.
54. The method in accordance with claim 51 including the step of lining the lumen of the stent with a vein segment prior to inserting the stent and catheter within the selected body passageway.
55. The method in accordance with claim 54 wherein the step of lining the lumen of the stent with a vein segment includes the steps of:
a) providing a vein segment having a length greater than the stent;
b) inserting the vein segment within the lumen of the stent; and c) everting ends of the vein segment over ends of the stent.
a) providing a vein segment having a length greater than the stent;
b) inserting the vein segment within the lumen of the stent; and c) everting ends of the vein segment over ends of the stent.
56. The method in accordance with claim 55 including stitching the everted ends to the stent.
57. A stent delivery apparatus for introducing and deploying an expandable, generally tubular stent within a selected body passageway including a drive unit and a catheter having a stent deployment mechanism connected with the drive unit, the stent deployment mechanism removably coupling with an exterior surface of the stent to apply an external, radially outwardly extending force on the stent from the exterior of the stent under control of the drive unit to expand the stent in the selected body passageway.
58. The stent delivery apparatus in accordance with claim 57 wherein the stent deployment mechanism comprises a plurality of spokes for removably attaching to the exterior of the stent.
59. The stent delivery apparatus in accordance with claim 58 wherein the stent deployment mechanism includes a central guidewire movable relative to the spokes and a leading tip mounted on an end of the central guidewire, the spokes having free ends releasably held within the tip whereupon movement of the guidewire under control of the drive unit in a direction displacing the tip away from the free ends of the spokes thereby releases the spokes from the tip.
60. The stent delivery apparatus in accordance with claim 58 wherein the stent deployment mechanism includes a central guidewire movable relative to the spokes and a leading tip mounted on an end of the guidewire, the spokes having fixed ends and free ends releasably held within the tip whereupon movement of the guidewire under control of the drive unit in a direction displacing the tip in a direction toward the fixed ends of the spokes causes the spokes to flex radially outwardly for exerting a radially outward force on the exterior of the stent to cause the stent to expand.
61. The stent delivery apparatus in accordance with claim 60 wherein movement of the guidewire under the control of the drive unit in a direction displacing the tip away from the free ends of the spokes thereby releases the spokes to enable decoupling of the stent deployment mechanism from the expanded stent.
62. The stent delivery apparatus in accordance with claim 57 wherein the drive unit comprises a manually-operable rack and pinion microdrive.
63. The stent delivery apparatus in accordance with claim 62 comprising a flexible control cable and wherein the drive unit is attached to the stent deployment mechanism with the flexible control cable.
64. The stent delivery apparatus in accordance with claim 57 wherein the stent deployment mechanism includes:
a) a plurality of spokes for removably coupling to the exterior of the stent, the spokes having free ends and fixed ends;
b) a bushing for holding the fixed ends of the spokes;
c) a central guidewire passing through the bushing and the tubular stent, the guidewire being movable relative to the spokes under the control of the drive unit; and d) a tip fixed to an end of the guidewire, the free ends of the spokes releasably nesting within the tip, whereupon movement of the guidewire under the control of the drive unit causes the tip to move in one direction to release the free ends of the spokes from the tip and causes the tip to move in another direction to outwardly flex the spokes.
a) a plurality of spokes for removably coupling to the exterior of the stent, the spokes having free ends and fixed ends;
b) a bushing for holding the fixed ends of the spokes;
c) a central guidewire passing through the bushing and the tubular stent, the guidewire being movable relative to the spokes under the control of the drive unit; and d) a tip fixed to an end of the guidewire, the free ends of the spokes releasably nesting within the tip, whereupon movement of the guidewire under the control of the drive unit causes the tip to move in one direction to release the free ends of the spokes from the tip and causes the tip to move in another direction to outwardly flex the spokes.
65. The stent delivery apparatus in accordance with claim 64 wherein the tip includes pivotable swing arms for releasably receiving the free ends of the spokes, the swing arms being movable in radial directions and planes generally parallel to the axis of the central guidewire.
66. The stent delivery apparatus in accordance with claim 65 wherein each of the swing arms includes a tubular arm for enabling removable insertion of a respective free end of one of the spokes.
67. The stent delivery apparatus in accordance with claim 66 wherein the bushing includes pivotable swing arms for attachment to the fixed ends of the spokes, the swing arms being movable in radial directions and planes generally parallel to the axis of the central guidewire.
68. A stent delivery system including:
a) a generally thin-walled, expandable, tubular stent with a central lumen having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter upon application of an outward radial force on the stent for retaining the tubular structure in the lumen of the body passageway; and b) a stent delivery apparatus for introducing and deploying the expandable stent within the selected body passage including a drive unit and a catheter having a stent deployment mechanism connected with the drive unit, the stent deployment mechanism removably coupling with an exterior surface of the stent to apply a radially outwardly extending force on the stent from the exterior of the stent under control of the drive unit.
a) a generally thin-walled, expandable, tubular stent with a central lumen having a first smaller diameter to enable delivery of the tubular structure into a selected body passageway having a lumen and a second enlarged diameter upon application of an outward radial force on the stent for retaining the tubular structure in the lumen of the body passageway; and b) a stent delivery apparatus for introducing and deploying the expandable stent within the selected body passage including a drive unit and a catheter having a stent deployment mechanism connected with the drive unit, the stent deployment mechanism removably coupling with an exterior surface of the stent to apply a radially outwardly extending force on the stent from the exterior of the stent under control of the drive unit.
69. The stent delivery system in accordance with claim 68 wherein the stent includes external expansion couplings mounted on an exterior surface of the tubular structure and wherein the stent deployment mechanism couples with the external expansion couplings for enabling the outward radial force to be applied externally of the tubular structure via the external expansion couplings.
70. The stent delivery system in accordance with claim 69 wherein the external expansion couplings include coupling tubes disposed on the exterior of the stent and the stent deployment mechanism includes a plurality of spokes for removable insertion within the coupling tubes for externally expanding the stent.
71. The stent in accordance with claim 8 wherein the vein segment includes a synthetic graft material.
72. The stent in accordance with claim 8 wherein the vein segment includes an autologous vein.
73. The graft in accordance with claim 24 wherein the vein segment includes an autologous vein.
74. The graft in accordance with claim 24 wherein the vein segment includes a synthetic graft material.
75. The stent in accordance with claim 41 wherein the vein segment includes a synthetic graft material.
76. The stent in accordance with claim 41 wherein the vein segment includes an autologous vein.
77. The stent in accordance with claim 34 wherein said struts include external expansion couplings having a first end connected with a rigid end support at one end of the stent and a second end connected with a rigid end support at the other end of the stent.
78. The stent in accordance with claim 77 wherein the external expansion couplings include coupling tubes.
79. The stent in accordance with claim 1 wherein said struts include external expansion couplings having a first end connected with a rigid end support at one end of the stent and a second end connected with a rigid end support at the other end of the stent.
80. The stent in accordance with claim 79 wherein the external expansion couplings include coupling tubes.
81. The delivery apparatus according to claim 64 wherein the tip includes a tubular section of flexible material with one end of the tubular section having flutes to releasably receive the free ends of the spokes.
82. The delivery apparatus according to claim 64 wherein the bushing includes a tubular section of flexible material with one end of the tubular section having flutes to receive the fixed ends of the spokes.
83. The delivery apparatus according to claim 64 wherein the tip includes angled bores to releasably hold the free ends of the spokes.
84. The delivery apparatus according to claim 83 further comprising a cylindrical section abutting against the tip with the central guidewire passing through the cylindrical section, the cylindrical section having external longitudinal slots aligned with the angled bores of the tip for receiving and controlling movement of the free ends of the spokes whereby movement of the free ends of the spokes is restrained to a radial direction relative to the cylindrical section.
85. The delivery apparatus according to claim 64 wherein the bushing includes angled bores to hold the fixed ends of the spokes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/309,359 | 1994-09-21 | ||
US08/309,359 US5702419A (en) | 1994-09-21 | 1994-09-21 | Expandable, intraluminal stents |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2200489A1 true CA2200489A1 (en) | 1996-03-28 |
Family
ID=23197899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002200489A Abandoned CA2200489A1 (en) | 1994-09-21 | 1995-08-30 | Expandable, intraluminal stents |
Country Status (4)
Country | Link |
---|---|
US (2) | US5702419A (en) |
AU (1) | AU3418395A (en) |
CA (1) | CA2200489A1 (en) |
WO (1) | WO1996009013A1 (en) |
Families Citing this family (221)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843167A (en) * | 1993-04-22 | 1998-12-01 | C. R. Bard, Inc. | Method and apparatus for recapture of hooked endoprosthesis |
EP0657147B1 (en) * | 1993-11-04 | 1999-08-04 | C.R. Bard, Inc. | Non-migrating vascular prosthesis |
US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
KR100452916B1 (en) * | 1995-07-25 | 2005-05-27 | 메드스텐트 인코퍼레이티드 | Expandible Stent |
US6261318B1 (en) | 1995-07-25 | 2001-07-17 | Medstent Inc. | Expandable stent |
IT1279628B1 (en) * | 1995-09-13 | 1997-12-16 | Xtrode Srl | DEVICE AND METHOD FOR ASSEMBLING A VASCULAR ENDOPROTHESIS ON A CATHETER FITTED WITH AN EXPANDABLE BALLOON |
CA2234389A1 (en) | 1995-10-13 | 1997-04-17 | Transvascular, Inc. | A device, system and method for interstitial transvascular intervention |
US5810868A (en) * | 1995-12-07 | 1998-09-22 | Arterial Vascular Engineering, Inc. | Stent for improved transluminal deployment |
CN1218414A (en) | 1996-02-02 | 1999-06-02 | 血管转换公司 | Methods and apparatus for blocking flow through blood vessels |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
NZ331269A (en) * | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
US6929481B1 (en) * | 1996-09-04 | 2005-08-16 | Immersion Medical, Inc. | Interface device and method for interfacing instruments to medical procedure simulation systems |
US6432127B1 (en) | 1996-10-11 | 2002-08-13 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US6395017B1 (en) * | 1996-11-15 | 2002-05-28 | C. R. Bard, Inc. | Endoprosthesis delivery catheter with sequential stage control |
US5868782A (en) * | 1996-12-24 | 1999-02-09 | Global Therapeutics, Inc. | Radially expandable axially non-contracting surgical stent |
US5776162A (en) * | 1997-01-03 | 1998-07-07 | Nitinol Medical Technologies, Inc. | Vessel implantable shape memory appliance with superelastic hinged joint |
US8663311B2 (en) * | 1997-01-24 | 2014-03-04 | Celonova Stent, Inc. | Device comprising biodegradable bistable or multistable cells and methods of use |
EP1656892A3 (en) * | 1997-01-24 | 2006-05-31 | Paragon Intellectual Properties, LLC | Expandable device comprising bistable unit cells |
US8353948B2 (en) * | 1997-01-24 | 2013-01-15 | Celonova Stent, Inc. | Fracture-resistant helical stent incorporating bistable cells and methods of use |
US5968053A (en) * | 1997-01-31 | 1999-10-19 | Cardiac Assist Technologies, Inc. | Method and apparatus for implanting a graft in a vessel of a patient |
US5810838A (en) * | 1997-03-13 | 1998-09-22 | Solar; Ronald J. | Hydraulic method and apparatus for uniform radial compression and catheter mounting of radially expandable intraluminal stents and stented grafts |
US5853419A (en) * | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US6168616B1 (en) | 1997-06-02 | 2001-01-02 | Global Vascular Concepts | Manually expandable stent |
EP0988081A1 (en) * | 1997-06-04 | 2000-03-29 | Advanced Cardiovascular Systems, Inc. | Steerable guidewire with enhanced distal support |
ES2290995T3 (en) | 1997-09-24 | 2008-02-16 | Med Institute, Inc. | RADIALLY EXPANDABLE ENDOPROTESIS. |
CA2304653C (en) * | 1997-10-01 | 2005-07-05 | Srinivas Nishtala | Dilation systems and related methods |
US6071308A (en) | 1997-10-01 | 2000-06-06 | Boston Scientific Corporation | Flexible metal wire stent |
US6330884B1 (en) | 1997-11-14 | 2001-12-18 | Transvascular, Inc. | Deformable scaffolding multicellular stent |
WO1999055257A1 (en) | 1998-04-30 | 1999-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Expandable space frame |
US6497724B1 (en) | 1999-04-30 | 2002-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Expandable space frame |
AU4409599A (en) | 1998-05-28 | 1999-12-13 | Georgia Tech Research Corporation | Autologous vascular grafts created by vessel distension |
US6641576B1 (en) * | 1998-05-28 | 2003-11-04 | Georgia Tech Research Corporation | Devices for creating vascular grafts by vessel distension using rotatable elements |
US6663617B1 (en) | 1998-05-28 | 2003-12-16 | Georgia Tech Research Corporation | Devices for creating vascular grafts by vessel distension using fixed post and moveable driver elements |
FR2779939B1 (en) * | 1998-06-17 | 2000-09-15 | Perouse Implant Lab | DEVICE FOR TREATING A BLOOD VESSEL |
US6896690B1 (en) * | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US6231597B1 (en) * | 1999-02-16 | 2001-05-15 | Mark E. Deem | Apparatus and methods for selectively stenting a portion of a vessel wall |
US6210318B1 (en) | 1999-03-09 | 2001-04-03 | Abiomed, Inc. | Stented balloon pump system and method for using same |
US6273910B1 (en) | 1999-03-11 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
HUP0201111A3 (en) | 1999-04-26 | 2004-05-28 | Gmp Vision Solutions Inc Ft La | Shunt device for treating glaucoma |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6409757B1 (en) * | 1999-09-15 | 2002-06-25 | Eva Corporation | Method and apparatus for supporting a graft assembly |
US6537310B1 (en) | 1999-11-19 | 2003-03-25 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal implantable devices and method of making same |
US10172730B2 (en) | 1999-11-19 | 2019-01-08 | Vactronix Scientific, Llc | Stents with metallic covers and methods of making same |
US7736687B2 (en) | 2006-01-31 | 2010-06-15 | Advance Bio Prosthetic Surfaces, Ltd. | Methods of making medical devices |
US7708711B2 (en) | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US6808533B1 (en) | 2000-07-28 | 2004-10-26 | Atrium Medical Corporation | Covered stent and method of covering a stent |
US6799637B2 (en) | 2000-10-20 | 2004-10-05 | Schlumberger Technology Corporation | Expandable tubing and method |
NO335594B1 (en) | 2001-01-16 | 2015-01-12 | Halliburton Energy Serv Inc | Expandable devices and methods thereof |
US6743210B2 (en) * | 2001-02-15 | 2004-06-01 | Scimed Life Systems, Inc. | Stent delivery catheter positioning device |
US6949929B2 (en) * | 2003-06-24 | 2005-09-27 | Biophan Technologies, Inc. | Magnetic resonance imaging interference immune device |
US20050283214A1 (en) * | 2003-08-25 | 2005-12-22 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288753A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288750A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
WO2002067782A2 (en) † | 2001-02-26 | 2002-09-06 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
WO2002071980A2 (en) * | 2001-03-09 | 2002-09-19 | Georgia Tech Research Corporation | Intravascular device and method for axially stretching blood vessels |
US6981958B1 (en) | 2001-05-02 | 2006-01-03 | Glaukos Corporation | Implant with pressure sensor for glaucoma treatment |
WO2002080811A2 (en) | 2001-04-07 | 2002-10-17 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US7488303B1 (en) | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
US6666841B2 (en) | 2001-05-02 | 2003-12-23 | Glaukos Corporation | Bifurcatable trabecular shunt for glaucoma treatment |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US7678065B2 (en) | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
WO2002089699A2 (en) | 2001-05-03 | 2002-11-14 | Glaukos Corporation | Medical device and methods of use for glaucoma treatment |
US6981964B2 (en) | 2001-05-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Draining bodily fluids with a stent |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
US6926732B2 (en) | 2001-06-01 | 2005-08-09 | Ams Research Corporation | Stent delivery device and method |
WO2002098296A1 (en) * | 2001-06-05 | 2002-12-12 | Apex Medical, Inc. | Pressure sensing endograft |
US6605110B2 (en) | 2001-06-29 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stent with enhanced bendability and flexibility |
US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
US6790223B2 (en) | 2001-09-21 | 2004-09-14 | Scimed Life Systems, Inc. | Delivering a uretheral stent |
US20030097151A1 (en) * | 2001-10-25 | 2003-05-22 | Smedley Gregory T. | Apparatus and mitochondrial treatment for glaucoma |
US7163543B2 (en) | 2001-11-08 | 2007-01-16 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7147656B2 (en) * | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US20030135269A1 (en) * | 2002-01-16 | 2003-07-17 | Swanstrom Lee L. | Laparoscopic-assisted endovascular/endoluminal graft placement |
US7186232B1 (en) | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
US7951155B2 (en) | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US7780687B2 (en) * | 2002-04-17 | 2010-08-24 | Tyco Healthcare Group Lp | Method and apparatus for anastomosis including expandable anchor |
US6761731B2 (en) * | 2002-06-28 | 2004-07-13 | Cordis Corporation | Balloon-stent interaction to help reduce foreshortening |
AU2003258240A1 (en) | 2002-08-15 | 2004-03-03 | Gmp Cardiac Care, Inc | Stent-graft with rails |
US7485139B1 (en) * | 2002-10-10 | 2009-02-03 | Ciamacco Jr Sam | Stent delivery and deployment system |
US7942898B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Delivery systems and methods for gastric reduction |
US7942884B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Methods for reduction of a gastric lumen |
US7763062B2 (en) * | 2003-01-21 | 2010-07-27 | Boston Scientific Scimed, Inc. | Method and system for delivering and implanting a graft |
US7377937B2 (en) * | 2003-04-22 | 2008-05-27 | Medtronic Vascular, Inc. | Stent-graft assembly with elution openings |
US20050131520A1 (en) | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
US7998188B2 (en) | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
US7651529B2 (en) | 2003-05-09 | 2010-01-26 | Boston Scientific Scimed, Inc. | Stricture retractor |
US7839146B2 (en) * | 2003-06-24 | 2010-11-23 | Medtronic, Inc. | Magnetic resonance imaging interference immune device |
US8868212B2 (en) | 2003-08-25 | 2014-10-21 | Medtronic, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288755A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288756A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US7344559B2 (en) * | 2003-08-25 | 2008-03-18 | Biophan Technologies, Inc. | Electromagnetic radiation transparent device and method of making thereof |
US20050283213A1 (en) * | 2003-08-25 | 2005-12-22 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US20050288757A1 (en) * | 2003-08-25 | 2005-12-29 | Biophan Technologies, Inc. | Medical device with an electrically conductive anti-antenna member |
US8500792B2 (en) | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US11596537B2 (en) | 2003-09-03 | 2023-03-07 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US11259945B2 (en) | 2003-09-03 | 2022-03-01 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US20070198078A1 (en) | 2003-09-03 | 2007-08-23 | Bolton Medical, Inc. | Delivery system and method for self-centering a Proximal end of a stent graft |
US9198786B2 (en) | 2003-09-03 | 2015-12-01 | Bolton Medical, Inc. | Lumen repair device with capture structure |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US7763063B2 (en) | 2003-09-03 | 2010-07-27 | Bolton Medical, Inc. | Self-aligning stent graft delivery system, kit, and method |
US20080264102A1 (en) | 2004-02-23 | 2008-10-30 | Bolton Medical, Inc. | Sheath Capture Device for Stent Graft Delivery System and Method for Operating Same |
CA2540120A1 (en) * | 2003-09-30 | 2005-04-14 | Alveolus Inc. | Active stent |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050273150A1 (en) | 2004-03-31 | 2005-12-08 | Howell Douglas D | Stent introducer system |
EP1738793A4 (en) * | 2004-04-16 | 2011-09-07 | Kawasumi Lab Inc | Stent graft indwelling device and fixed chip |
US8257394B2 (en) | 2004-05-07 | 2012-09-04 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
WO2005112824A1 (en) * | 2004-05-14 | 2005-12-01 | Boston Scientific Scimed, Inc | Stent delivery handle and assembly formed therewith |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
DE102004044679A1 (en) * | 2004-09-09 | 2006-03-16 | Biotronik Vi Patent Ag | Implant with low radial strength |
US20110068834A1 (en) * | 2005-01-07 | 2011-03-24 | Trustees Of Boston University | Electro-mechanical oscillating devices and associated methods |
WO2006082574A2 (en) * | 2005-02-01 | 2006-08-10 | Shifrin Edward G | Apparatus and method for delivery and double-ended fixation of vascular grafts or stent-grafts |
US20090132021A1 (en) * | 2005-02-01 | 2009-05-21 | Shifrin Edward G | Apparatus and method for delivery, spreading and double-ended fixation of vascular grafts |
USRE47376E1 (en) * | 2005-04-01 | 2019-05-07 | Nexgen Medical Systems, Incorporated | Thrombus removal system and process |
US7763198B2 (en) | 2005-04-12 | 2010-07-27 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US7947207B2 (en) | 2005-04-12 | 2011-05-24 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US8628565B2 (en) | 2005-04-13 | 2014-01-14 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US7547311B2 (en) * | 2005-05-03 | 2009-06-16 | Ethicon Endo-Surgery, Inc. | Spring-based firing mechanism for anastomotic ring applier |
US20070100231A1 (en) * | 2005-05-19 | 2007-05-03 | Biophan Technologies, Inc. | Electromagnetic resonant circuit sleeve for implantable medical device |
ES2356174T3 (en) * | 2005-07-25 | 2011-04-05 | Invatec S.P.A. | ENDOLUMINAL PROSTHESIS WITH BIOABSORBABLE PARTS. |
US20070112372A1 (en) * | 2005-11-17 | 2007-05-17 | Stephen Sosnowski | Biodegradable vascular filter |
US20070156223A1 (en) * | 2005-12-30 | 2007-07-05 | Dennis Vaughan | Stent delivery system with improved delivery force distribution |
WO2007109621A2 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
GB0700560D0 (en) * | 2007-01-11 | 2007-02-21 | Emcision Ltd | Device and method for the treatment of diseased tissue such as tumours |
US8870916B2 (en) | 2006-07-07 | 2014-10-28 | USGI Medical, Inc | Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use |
EP3338735A1 (en) | 2006-07-19 | 2018-06-27 | Novate Medical Limited | A vascular filter |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US8768486B2 (en) * | 2006-12-11 | 2014-07-01 | Medtronic, Inc. | Medical leads with frequency independent magnetic resonance imaging protection |
EP2111189B1 (en) * | 2007-01-03 | 2017-04-05 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
JP5602010B2 (en) * | 2007-04-09 | 2014-10-08 | クレアトイベ スルギカル,エルエルシー | Frame device |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
US9603730B2 (en) | 2007-12-12 | 2017-03-28 | Intact Vascular, Inc. | Endoluminal device and method |
US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US9375327B2 (en) | 2007-12-12 | 2016-06-28 | Intact Vascular, Inc. | Endovascular implant |
US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
US8114116B2 (en) | 2008-01-18 | 2012-02-14 | Cook Medical Technologies Llc | Introduction catheter set for a self-expandable implant |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
DK2265193T3 (en) | 2008-04-21 | 2012-01-23 | Nfocus Neuromedical Inc | Embolic devices with braided ball and delivery systems |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
JP5484458B2 (en) | 2008-06-30 | 2014-05-07 | ボルトン メディカル インコーポレイテッド | Abdominal aortic aneurysm system |
AU2009274126A1 (en) | 2008-07-22 | 2010-01-28 | Covidien Lp | Vascular remodeling device |
AU2009288697B2 (en) * | 2008-09-05 | 2013-06-20 | Cook Medical Technologies Llc | Apparatus and methods for improved stent deployment |
US8992558B2 (en) | 2008-12-18 | 2015-03-31 | Osteomed, Llc | Lateral access system for the lumbar spine |
EP2381893B1 (en) | 2009-01-16 | 2018-03-07 | Novate Medical Ltd. | A vascular filter device |
US8057507B2 (en) | 2009-01-16 | 2011-11-15 | Novate Medical Limited | Vascular filter |
WO2010082189A1 (en) | 2009-01-16 | 2010-07-22 | Novate Medical Limited | A vascular filter system |
CN102355871B (en) * | 2009-01-16 | 2014-07-09 | 诺瓦特医疗有限公司 | A vascular filter device |
US8277477B2 (en) * | 2009-02-20 | 2012-10-02 | Paul Oberle | Mechanically deployable upper airway stent |
CN106551740B (en) * | 2009-03-13 | 2020-03-27 | 波顿医疗公司 | System and method for deploying an endoluminal prosthesis at a surgical site |
US8876877B2 (en) | 2009-04-23 | 2014-11-04 | Medtronic Vascular, Inc. | Centering for a TAA |
CN102740799A (en) | 2010-01-28 | 2012-10-17 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
US7879009B1 (en) | 2010-01-29 | 2011-02-01 | Warsaw Orthopedic, Inc. | Variable opening delivery system for intervertebral disc therapies |
JP5803010B2 (en) * | 2010-04-27 | 2015-11-04 | メドトロニック,インコーポレイテッド | Transcatheter prosthetic heart valve delivery device with deflection release characteristics |
US9561102B2 (en) * | 2010-06-02 | 2017-02-07 | Medtronic, Inc. | Transcatheter delivery system and method with controlled expansion and contraction of prosthetic heart valve |
PL3231401T3 (en) | 2010-06-24 | 2020-09-21 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Apparatus for pulling a tensile member from a medical device |
CA3069319C (en) * | 2010-07-08 | 2021-05-04 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US9572953B2 (en) * | 2010-12-30 | 2017-02-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Device having an electroformed pleated region and method of its manufacture |
JP5868432B2 (en) | 2011-02-11 | 2016-02-24 | コヴィディエン リミテッド パートナーシップ | Two-stage deployed aneurysm embolization device |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US10271973B2 (en) | 2011-06-03 | 2019-04-30 | Intact Vascular, Inc. | Endovascular implant |
US11026708B2 (en) | 2011-07-26 | 2021-06-08 | Thrombx Medical, Inc. | Intravascular thromboembolectomy device and method using the same |
EP4193907A1 (en) | 2011-09-13 | 2023-06-14 | Glaukos Corporation | Intraocular physiological sensor |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
EP3733134A1 (en) | 2012-01-25 | 2020-11-04 | Intact Vascular, Inc. | Endoluminal device |
EP2830553B1 (en) | 2012-03-26 | 2017-12-27 | Glaukos Corporation | Apparatus for delivering multiple ocular implants |
EP3141223A1 (en) | 2012-04-12 | 2017-03-15 | Bolton Medical, Inc. | Vascular prosthetic delivery device |
US10188536B2 (en) * | 2012-09-27 | 2019-01-29 | Symetis Sa | Stent-valve, delivery apparatus, and stent-holder therefor |
US10524909B2 (en) * | 2012-10-12 | 2020-01-07 | St. Jude Medical, Cardiology Division, Inc. | Retaining cage to permit resheathing of a tavi aortic-first transapical system |
US9750626B2 (en) | 2012-10-31 | 2017-09-05 | Cook Medical Technologies Llc | Apparatus and methods for improved stent deployment |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US9295571B2 (en) * | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9095344B2 (en) | 2013-02-05 | 2015-08-04 | Artventive Medical Group, Inc. | Methods and apparatuses for blood vessel occlusion |
US8984733B2 (en) | 2013-02-05 | 2015-03-24 | Artventive Medical Group, Inc. | Bodily lumen occlusion |
EP2956088A2 (en) | 2013-02-12 | 2015-12-23 | OssDsign AB | Mosaic implants, kits and methods for correcting bone defects |
US9220597B2 (en) * | 2013-02-12 | 2015-12-29 | Ossdsign Ab | Mosaic implants, kits and methods for correcting bone defects |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US9439751B2 (en) | 2013-03-15 | 2016-09-13 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
WO2014144980A1 (en) | 2013-03-15 | 2014-09-18 | Covidien Lp | Occlusive device |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
EP2967804A2 (en) | 2013-03-15 | 2016-01-20 | Novate Medical Ltd. | A vascular filter device |
US9636116B2 (en) * | 2013-06-14 | 2017-05-02 | Artventive Medical Group, Inc. | Implantable luminal devices |
US9737308B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US10149968B2 (en) | 2013-06-14 | 2018-12-11 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9737306B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Implantable luminal devices |
EP3113697B8 (en) | 2014-03-04 | 2019-09-18 | ThrombX Medical, Inc. | Intravascular thromboembolectomy device having a plurality of clot engaging elements |
JP6154082B2 (en) * | 2014-04-08 | 2017-06-28 | ストライカー コーポレイションStryker Corporation | Implant delivery system |
AU2015266850B2 (en) | 2014-05-29 | 2019-12-05 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
BR112017002863A2 (en) | 2014-08-14 | 2018-01-30 | Ossdsign Ab | bone implants for correction of bone defects |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9456914B2 (en) | 2015-01-29 | 2016-10-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9192500B1 (en) | 2015-01-29 | 2015-11-24 | Intact Vascular, Inc. | Delivery device and method of delivery |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10813644B2 (en) | 2016-04-01 | 2020-10-27 | Artventive Medical Group, Inc. | Occlusive implant and delivery system |
US11166709B2 (en) | 2016-08-23 | 2021-11-09 | Stryker European Operations Holdings Llc | Instrumentation and methods for the implantation of spinal implants |
US11628056B2 (en) | 2016-11-22 | 2023-04-18 | Cook Medical Technologies Llc | Graft for treating the distal aortic arch and descending aorta in type a patients |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
JP2020533153A (en) | 2017-09-11 | 2020-11-19 | スロンムエックス メディカル インコーポレイテッドThrombx Medical Inc. | Intravascular thromboembolectomy devices and methods |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
CN110573117B (en) | 2017-10-06 | 2021-10-26 | 格劳科斯公司 | Systems and methods for delivering multiple ocular implants |
USD846738S1 (en) | 2017-10-27 | 2019-04-23 | Glaukos Corporation | Implant delivery apparatus |
EP3545857B1 (en) | 2018-03-30 | 2024-01-03 | Stryker European Operations Holdings LLC | Lateral access retractor and core insertion |
CN111971001B (en) * | 2018-04-09 | 2023-09-12 | 波士顿科学国际有限公司 | Stent delivery system with reduced deployment force |
GB2579540B (en) * | 2018-11-16 | 2022-10-05 | Turnbull Infrastructure & Utilities Ltd | Pipe repair |
US11452533B2 (en) | 2019-01-10 | 2022-09-27 | Abbott Cardiovascular Systems Inc. | Guide wire tip having roughened surface |
US11564674B2 (en) | 2019-11-27 | 2023-01-31 | K2M, Inc. | Lateral access system and method of use |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2701559A (en) * | 1951-08-02 | 1955-02-08 | William A Cooper | Apparatus for exfoliating and collecting diagnostic material from inner walls of hollow viscera |
GB1205743A (en) * | 1966-07-15 | 1970-09-16 | Nat Res Dev | Surgical dilator |
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3774596A (en) * | 1971-06-29 | 1973-11-27 | G Cook | Compliable cavity speculum |
US3868956A (en) * | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
US3889685A (en) * | 1973-11-02 | 1975-06-17 | Cutter Lab | Tubular unit with vessel engaging cuff structure |
US3882845A (en) * | 1973-12-17 | 1975-05-13 | Investors In Ventures Inc | Methods and devices for reducing lumen constriction |
JPS5239596B2 (en) * | 1974-04-04 | 1977-10-06 | ||
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
US4141364A (en) * | 1977-03-18 | 1979-02-27 | Jorge Schultze | Expandable endotracheal or urethral tube |
US4183102A (en) * | 1977-09-08 | 1980-01-15 | Jacques Guiset | Inflatable prosthetic device for lining a body duct |
US4299226A (en) * | 1979-08-08 | 1981-11-10 | Banka Vidya S | Coronary dilation method |
US4564014A (en) * | 1980-01-30 | 1986-01-14 | Thomas J. Fogarty | Variable length dilatation catheter apparatus and method |
US4328811A (en) * | 1980-07-28 | 1982-05-11 | Fogarty Thomas J | Calibrating dilation catheter |
US4318410A (en) * | 1980-08-07 | 1982-03-09 | Thomas J. Fogarty | Double lumen dilatation catheter |
US4338942A (en) * | 1980-10-20 | 1982-07-13 | Fogarty Thomas J | Dilatation catherter apparatus |
US4483340A (en) * | 1980-10-20 | 1984-11-20 | Thomas J. Fogarty | Dilatation catheter |
US4403612A (en) * | 1980-10-20 | 1983-09-13 | Fogarty Thomas J | Dilatation method |
US4416028A (en) * | 1981-01-22 | 1983-11-22 | Ingvar Eriksson | Blood vessel prosthesis |
AU8954282A (en) * | 1981-09-16 | 1983-04-08 | Wallsten, H.I. | Device for application in blood vessels or other difficultly accessible locations and its use |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4483339A (en) * | 1982-01-29 | 1984-11-20 | Rolando Gillis | Vascular surgery roll |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4503569A (en) * | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4560374A (en) * | 1983-10-17 | 1985-12-24 | Hammerslag Julius G | Method for repairing stenotic vessels |
US4562596A (en) * | 1984-04-25 | 1986-01-07 | Elliot Kornberg | Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair |
JPS60187737U (en) * | 1984-05-23 | 1985-12-12 | オリンパス光学工業株式会社 | Indwelling tube guide device |
US4619261A (en) * | 1984-08-09 | 1986-10-28 | Frederico Guerriero | Hydrostatic pressure device for bleeding control through an inflatable, stitchable and retrievable balloon-net system |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
JPS6198254A (en) * | 1984-10-19 | 1986-05-16 | ザ・ベントリー―ハリス・マニュファクチュアリング・カンパニー | Prosthetic stent |
US4577631A (en) * | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
US4807626A (en) * | 1985-02-14 | 1989-02-28 | Mcgirr Douglas B | Stone extractor and method |
US4650466A (en) * | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
EP0257091B1 (en) * | 1986-02-24 | 1993-07-28 | Robert E. Fischell | An intravascular stent and percutaneous insertion system |
US4793348A (en) * | 1986-11-15 | 1988-12-27 | Palmaz Julio C | Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation |
GB2221601B (en) * | 1986-11-21 | 1990-12-19 | David Brian Johnson | Container blanks and containers |
US4762128A (en) * | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4893623A (en) * | 1986-12-09 | 1990-01-16 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4907336A (en) * | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US5192307A (en) * | 1987-12-08 | 1993-03-09 | Wall W Henry | Angioplasty stent |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US5609626A (en) * | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5035706A (en) * | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
JP2672178B2 (en) * | 1990-05-15 | 1997-11-05 | ファナック株式会社 | Rotor structure of synchronous motor |
US5360443A (en) * | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
US5108417A (en) * | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5496365A (en) | 1992-07-02 | 1996-03-05 | Sgro; Jean-Claude | Autoexpandable vascular endoprosthesis |
US5342297A (en) * | 1992-07-10 | 1994-08-30 | Jang G David | Bailout receptacle for angioplasty catheter |
DE4300285A1 (en) * | 1993-01-08 | 1994-07-14 | Wolf Gmbh Richard | Instrument for implanting and extracting stents |
US5403341A (en) * | 1994-01-24 | 1995-04-04 | Solar; Ronald J. | Parallel flow endovascular stent and deployment apparatus therefore |
FR2715598B1 (en) | 1994-02-02 | 1996-04-12 | Danel Technology | Tool holder for medical or surgical tool and robot comprising such a tool holder. |
US5549663A (en) * | 1994-03-09 | 1996-08-27 | Cordis Corporation | Endoprosthesis having graft member and exposed welded end junctions, method and procedure |
US5733303A (en) * | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
CA2188563C (en) * | 1994-04-29 | 2005-08-02 | Andrew W. Buirge | Stent with collagen |
US5522881A (en) * | 1994-06-28 | 1996-06-04 | Meadox Medicals, Inc. | Implantable tubular prosthesis having integral cuffs |
US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
US5630829A (en) | 1994-12-09 | 1997-05-20 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5556414A (en) * | 1995-03-08 | 1996-09-17 | Wayne State University | Composite intraluminal graft |
US5591197A (en) * | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
-
1994
- 1994-09-21 US US08/309,359 patent/US5702419A/en not_active Expired - Fee Related
-
1995
- 1995-08-30 AU AU34183/95A patent/AU3418395A/en not_active Abandoned
- 1995-08-30 CA CA002200489A patent/CA2200489A1/en not_active Abandoned
- 1995-08-30 WO PCT/US1995/010931 patent/WO1996009013A1/en active Application Filing
-
1997
- 1997-11-26 US US08/979,433 patent/US6248128B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5702419A (en) | 1997-12-30 |
AU3418395A (en) | 1996-04-09 |
US6248128B1 (en) | 2001-06-19 |
WO1996009013A1 (en) | 1996-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5702419A (en) | Expandable, intraluminal stents | |
US5861025A (en) | Tubular expandable member for an intraluminal endoprosthesis, intraluminal endoprosthesis, and method of production | |
EP1621160B1 (en) | Low deployment force delivery device | |
EP1492473B1 (en) | System for deploying multi-part endoluminal devices | |
JP4201354B2 (en) | Disposable delivery device for endoluminal prosthesis | |
Knudsen et al. | Catheter-Implanted Prosthetic Heart Valves: Transluminal catheter implantation of a new expandable artificial heart valve in the descending thoracic aorta in isolated vessels and closed chest pigs | |
US5211658A (en) | Method and device for performing endovascular repair of aneurysms | |
EP0714270B1 (en) | A tubular intraluminally insertable graft | |
CA2178549C (en) | Coupling device and method of use | |
US6019778A (en) | Delivery apparatus for a self-expanding stent | |
US5556414A (en) | Composite intraluminal graft | |
JP2771001B2 (en) | Artificial and endograft methods | |
US5989263A (en) | Hydraulically actuated dilatation mechanism for vessel dilatation and vascular prosthesis delivery and methods of use | |
US20120035701A1 (en) | Stent strut appositioner | |
EP0177330A2 (en) | Percutaneous endovascular stent | |
US20070032850A1 (en) | Separable sheath and method for insertion of a medical device into a bodily vessel using a separable sheath | |
JP2005525832A (en) | Method and apparatus for measuring compliance of stents and stented grafts | |
JPH11501244A (en) | Endoluminal prosthesis placement means that can be used for various length prostheses and has a retrieval function | |
WO2003071987A1 (en) | Apparatus and method for deployment of an endoluminal device | |
WO1999043379A9 (en) | Delivery system and method for deployment and endovascular assembly of multi-stage stent graft | |
WO2001085064A1 (en) | Multilayer stents having enhanced flexibility and hoop strength | |
AU9091198A (en) | Non-thrombogenic stent jacket | |
WO2006019712A1 (en) | Stent with extruded covering | |
WO1999049790A1 (en) | Reduced friction graft and stent/graft deployment catheter | |
CN215228889U (en) | Support conveying system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |